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ABSTRRACT 
This descriptive cross-sectional study was carried out in seven health facilities to determine the 
Human Immuno-deficiency Virus (HIV) sero-prevalence and risk behaviors among two groups of 
tuberculosis patients in Khartoum State. Three hundred and two patients were screened for HIV 
infection by using an Enzyme Immuno-assay (EIA) test and reactive specimens were confirmed 
by another EIA test of different formatting.  
 Three hundred and two patients were interviewed by using structured pre-tested questionnaire 
which consisted of six sections concerned with the socio- demographic profile of the respondents, 
awareness about HIV/AIDS, its mode of transmission and prevention, recognition and use of 
male condom, history of sexually transmitted infections, available mass media, history of TB 
disease and treatment. 
The epidemiological survey results revealed that the overall HIV seroprevalence among the 
patients was 7.6%. Bivariate analysis revealed that, age and gender have no effect on the 
susceptibility of the TB patients to get HIV infection. 
Median age of respondents of the first group among whom sero-survey was carried out was 31 
years and gender ratio between males and females was 2.5: 1. 
Socio-demographic profile of the second group showed that median age of participants was also 
31 years. Gender ratio between males and females was 1.8:1.          
More than 40% of the respondents were illiterate and 48.7% were originally from the Western 
States of the Sudan. One fifth of the patients had previous blood transfusion or surgical 
interventions. 
The majority of the patients (73.5%) were aware of AIDS and there was a statistical significant 
difference between males and females, among age groups, different occupations and education 
levels, regarding knowledge about AIDS and male condom(p<0.001). 
 VIII
About 48% could recognize a single symptom of AIDS and 54% could not identify the germ that 
causes it and 21.2% do not know any prevention method. 
Only 9.3% of the patients had been tested before for HIV infection. 
About 79% never saw or heard about the male condom and 80.8% said had never had any sexual 
relations before and only 2% had been sexually active before marriage. 
A total of 16.3% of patients complained of different STIs symptoms. 
Only 20.2% of respondents received educational material about AIDS. 
Sixty nine percent of the patients had the TB disease for a year or less. 
From this study it is concluded that the HIV seroprevalence among TB patients is higher than in 
previous survey conducted by the Sudan National AIDS Control Programme in 2002 and the 
information and education about HIV/AIDS are still weak. 
It is recommended to make use of all available sources that would ensure maximum spread of 
information regarding HIV transmission, prevention and control and efforts should be intensified 
to provide HIV screening for all TB patients.                 
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  ﻣﻠﺨﺺ  اﻷﻃﺮوﺣﺔ
ﻩ ﺍﻟﻤﻘﻁﻌﻴﺔ ﺍﻟﻭﺼﻔﻴﺔ  ﻓﻲ ﺴﺒﻌﺔ ﻭﺤﺩﺍﺕ ﻟﺘﺤﺩﻴﺩ ﺍﻻﻨﺘﺸﺎﺭ ﺍﻟﻤﺼﻠﻲ ﻟﻔﻴﺭﻭﺱ ﻨﻘﺹ ﺃﺠﺭﻴﺕ  ﻫﺫ 
  .ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺭﻴﺔ ﻭﺴﻠﻭﻙ ﺍﻟﺨﻁﻭﺭﺓ ﺒﻴﻥ ﻤﺠﻤﻭﻋﺘﻴﻥ ﻤﻥ ﻤﺭﻀﻰ ﺍﻟﺩﺭﻥ ﺒﻭﻻﻴﺔ ﺍﻟﺨﺭﻁﻭﻡ 
ﺘﻡ ﺘﻘﺼﻲ ﺤﺎﻟﺔ ﺜﻼﺜﻤﺎﺌﺔ ﻭﺍﺜﻨﻴﻥ ﻤﺭﻴﺽ ﻟﺘﺤﺩﻴﺩ ﻭﺠﻭﺩ ﺍﻹﺼﺎﺒﺔ ﺒﻔﻴﺭﻭﺱ ﻨﻘﺹ ﺍﻟﻤﻨﺎﻋﺔ   
ﻭﺘﻡ ﺍﻟﺘﺄﻜﺩ ﻤﻥ ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﻤﺘﻔﺎﻋﻠﺔ ( AIE)ﺯﻴﻤﻴﺔ ﺍﻟﺒﺸﺭﻴﺔ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺍﻟﻤﻨﺎﻋﻴﺔ ﺍﻷﻨ
  .ﺒﺎﺴﺘﺨﺩﺍﻡ ﻨﻭﻉ ﺁﺨﺭ ﻤﻥ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺍﻷﻨﺯﻴﻤﻴﺔ 
ﺘﻤﺕ ﻤﻌﺎﻴﻨﺔ ﺜﻼﺜﻤﺎﺌﺔ ﻭﺍﺜﻨﻴﻥ ﻤﺭﻴﺽ ﺁﺨﺭﻴﻥ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻻﺴﺘﺒﻴﺎﻥ ﺍﻟﻤﻭﺠﻪ ﺍﻟﻘﺒﻠﻲ ﺍﻟﺫﻱ ﻴﺤﺘﻭﻱ    
ﻟﻠﻤﺴﺘﺠﻴﺒﻴﻥ ، ﻤﺩﻯ ﺍﻹﻟﻤﺎﻡ ﺒﻔﻴﺭﻭﺱ ( ﺍﻟﺴﻜﺎﻨﻴﺔ)ﻋﻠﻰ ﺴﺘﺔ ﻤﺤﺎﻭﺭ ﻫﻲ ﺍﻟﺒﻴﺎﻨﺎﺕ ﺍﻟﺩﻴﻤﻐﺭﺍﻓﻴﺔ  
ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺭﻴﺔ ، ﻁﺭﻴﻘﺔ ﺍﻻﻨﺘﻘﺎل ﻭﺍﻟﻭﻗﺎﻴﺔ ، ﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﻭﺍﻗﻲ ﺍﻟﺫﻜﺭﻱ ، ﺘﺎﺭﻴﺦ ﺍﻷﻤﺭﺍﺽ ﻨﻘﺹ 
  .ﺍﻟﻤﻨﻘﻭﻟﺔ ﺠﻨﺴﻴﺎ ﻭﺴﺒل ﺍﻷﻋﻼﻡ ﺍﻟﻤﺘﺎﺤﺔ ﻭﺘﺎﺭﻴﺦ ﺍﻹﺼﺎﺒﺔ ﺒﻤﺭﺽ ﺍﻟﺩﺭﻥ ﻭﺍﻟﻌﻼﺝ 
  .ﺒﻴﻥ ﻫﻭﻻﺀ ﺍﻟﻤﺭﻀﻰ % 6.7ﺃﻭﻀﺤﺕ ﻨﺘﻴﺠﺔ ﺒﺤﺙ ﺍﻟﻭﺒﺎﺌﻴﺎﺕ ﺃﻥ ﻨﺴﺒﺔ ﺍﻻﻨﺘﺸﺎﺭ      
ﺩﺩﻱ ﺃﻥ ﺍﻟﻌﻤﺭ ﻭﺍﻟﻨﻭﻉ ﻟﻴﺱ ﺫﻭﻱ ﺃﺜﺭ ﻟﻘﺎﺒﻠﻴﺔ ﻤﺭﻀﻰ ﺍﻟﺩﺭﻥ ﺃﻭﻀﺢ ﺍﻟﺘﺤﻠﻴل ﻟﻠﻤﺘﻐﻴﺭ ﺍﻟﺘﻌ     
  .ﻟﻺﺼﺎﺒﺔ ﺒﺨﻤﺔ ﻨﻘﺹ ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺭﻴﺔ 
 ﺴﻨﺔ ﺒﻴﻥ ﺍﻟﻤﺤﺩﺩ ﻟﻬﻡ ﺍﻟﻤﺴﺢ 13ﺇﻥ ﺍﻟﻌﻤﺭ ﺍﻟﻭﺴﻁﻲ ﻟﻠﻤﺴﺘﺠﻴﺒﻴﻥ ﺒﺎﻟﻤﺠﻤﻭﻋﺔ ﺍﻷﻭﻟﻰ      
   .1:5:2ﺍﻟﻤﺼﻠﻲ ﻭﻨﺴﺒﺔ ﺍﻟﺫﻜﻭﺭ ﻟﻺﻨﺎﺙ 
 13ﻥ ﺍﻟﻌﻤﺭ ﺍﻟﻭﺴﻁﻲ  ﻜﺫﻟﻙ  ﺃﻭﻀﺤﺕ ﺍﻟﺼﻴﻐﺔ ﺍﻟﺴﻜﺎﻨﻴﺔ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ  ﻟﻠﻤﺠﻤﻭﻋﺔ ﺍﻟﺜﺎﻨﻴﺔ ﺃ      
   .1:8:1ﺴﻨﺔ ﻭﻨﺴﺒﺔ ﺍﻟﺫﻜﻭﺭ ﻟﻺﻨﺎﺙ 
% 7.84ﻭ ( ﺃﻤﻴﻴﻥ)ﻤﻥ ﺍﻟﻤﺴﺘﺠﻴﺒﻴﻥ ﻻ ﻴﺠﻴﺩﻭﻥ ﺍﻟﻘﺭﺍﺀﺓ ﻭﺍﻟﻜﺘﺎﺒﺔ %  04ﻭﺠﺩ ﺃﻥ ﺃﻜﺜﺭ ﻤﻥ      
  .ﻫﻡ ﻤﻥ ﺍﻟﻭﻻﻴﺎﺕ ﺍﻟﻐﺭﺒﻴﺔ ﺒﺎﻟﺴﻭﺩﺍﻥ 
  .ﺨﻤﺱ ﺍﻟﻤﺭﻀﻰ ﺘﻡ ﻟﻬﻡ ﻨﻘل ﺩﻡ ﺴﺎﺒﻕ ﺃﻭ ﻤﺩﺍﺨﻠﺔ ﺠﺭﺍﺤﻴﺔ      
ﻹﻟﻤﺎﻡ ﺒﻤﺭﺽ ﺍﻻﻴﺩﺯ ﻤﻊ ﻭﺠﻭﺩ ﻓﺭﻭﻗﺎﺕ ﺫﺍﺕ ﺩﻻﻟﺔ ﺇﺤﺼﺎﺌﻴﺔ ﺒﻴﻥ ﻟﺩﻴﻬﻡ ﺍ%( 5.37)  ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻰ 
 <P. ) ﺍﻟﺫﻜﻭﺭ ﻭﺍﻹﻨﺎﺙ ، ﺒﻴﻥ ﺍﻟﻔﺌﺎﺕ ﺍﻟﻌﻤﺭﻴﺔ ، ﻤﺴﺘﻭﻯ ﺍﻟﺘﻌﻠﻴﻡ ﻭﺍﻟﻤﻌﺭﻓﺔ ﺒﺎﻻﻴﺩﺯ ﻭﺍﻟﻭﺍﻗﻲ ﺍﻟﺫﻜﺭﻱ 
  ( . 100.0
 
 
 
01 
 ﺩﻯ ﺍﻷﻋﺭﺍﺽ ﺍﻟﻤﺭﻀﻴﺔ ﻟﻨﻘﺹ ﺍﻟﻤﻨﺎﻋﺔﻴﻤﻜﻨﻬﻡ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻰ ﺇﺤ% 84ﻭﺠﺩ ﺃﻥ ﻨﺴﺒﺔ      
ﻟﻴﺱ ﻟﺩﻴﻬﻡ  ﺃﺩﻨﻰ %  2.12ﻡ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻰ ﺍﻟﺠﺭﺜﻭﻤﺔ ﺍﻟﻤﺴﺒﺒﺔ ﻟﻪ ، ﺍﻟﺒﺸﺭﻴﺔ ﺒﻴﻨﻤﺎ ﻻ ﻴﻤﻜﻨﻬ
  .ﻤﻌﺭﻓﺔ ﺒﻁﺭﻕ ﺍﻟﻭﻗﺎﻴﺔ 
  
% 5.87ﻓﻘﻁ ﻤﻥ ﺍﻟﻤﺭﻀﻰ ﻗﺒل ﺍﻹﺼﺎﺒﺔ ﺒﻨﻘﺹ ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺭﻴﺔ ﻭ % 3.9ﺘﻡ ﺍﻟﻜﺸﻑ ﻋﻠﻰ      
  .ﻤﻨﻬﻡ ﻟﻡ ﻴﺘﺎﺡ ﻟﻬﻡ ﺍﻟﻤﺸﺎﻫﺩﺓ ﺃﻭ ﺍﻟﺴﻤﺎﻉ ﻋﻥ ﺍﻟﻭﺍﻗﻲ ﺍﻟﺫﻜﺭﻱ 
  
ﻓﻘﻁ % 2ﻴﺔ  ﺨﺎﺭﺝ ﺭﺒﺎﻁ ﺍﻟﺯﻭﺠﻴﺔ ﻤﻥ ﻗﺒل ﻭﻤﻨﻬﻡ ﺒﻌﺩﻡ ﻭﺠﻭﺩ ﻋﻼﻗﺔ ﺇﺭﺘﺒﺎﻁ% 8.08ﺃﻓﺎﺩ     
  .ﻜﺎﻨﺕ ﻟﺩﻴﻬﻡ ﻋﻼﻗﺔ ﻨﺸﻁﺔ ﻗﺒل ﺍﻟﺯﻭﺍﺝ 
  
% 2.02ﻤﻥ ﺍﻟﻤﺭﻀﻰ ﻤﻥ ﺃﻋﺭﺍﺽ ﻤﺨﺘﻠﻔﺔ ﻟﻸﻤﺭﺍﺽ ﺍﻟﻤﻨﻘﻭﻟﺔ ﺠﻨﺴﻴﺎ  % 3.61 ﻭﺍﺸﺘﻜﻰ     
  .ﻓﻘﻁ ﻤﻥ ﺍﻟﻤﺴﺘﺠﻴﺒﻴﻥ ﺃﻋﻁﻭﺍ ﻨﺸﺭﺍﺕ ﺘﻌﻠﻴﻤﻴﺔ ﻋﻥ ﺍﻻﻴﺩﺯ 
  
  .ﻜﺎﻥ ﻟﺩﻴﻬﻡ ﻤﺭﺽ ﺍﻟﺩﺭﻥ ﻟﻤﺩﺓ ﺴﻨﺔ  ﺃﻭ ﺃﻗل %  96 ﻭﺠﺩ ﺃﻥ      
  
ﺨﻠﺼﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻰ ﺃﻥ ﺍﻻﻨﺘﺸﺎﺭ ﺍﻟﻤﺼﻠﻲ ﺒﻴﻥ ﻤﺭﺽ ﺍﻻﻴﺩﺯ  ﺃﻋﻠﻰ ﺒﻜﺜﻴﺭ ﻤﻥ ﺍﻟﻤﺴﺢ ﺍﻟﺴﺎﺒﻕ     
ﻡ  ﻭﺍﻟﻤﻌﻠﻭﻤﺎﺕ 2002ﺍﻟﺫﻱ ﺃﺠﺭﻱ ﻋﺒﺭ  ﺍﻟﺒﺭﻨﺎﻤﺞ ﺍﻟﻘﻭﻤﻲ ﺍﻟﺴﻭﺩﺍﻨﻲ ﻟﻤﻜﺎﻓﺤﺔ ﺍﻻﻴﺩﺯ ﻓﻲ ﻋﺎﻡ 
  .ﻤﺎ ﺯﺍﻟﺕ ﻀﻌﻴﻔﺔ ( ﺍﻻﻴﺩﺯ)ﻭﺍﻟﺘﺜﻘﻴﻑ ﻋﻥ ﺨﻤﺔ ﻨﻘﺹ ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺭﻴﺔ 
  
ﺎﺌل ﺍﻟﻤﺘﺎﺤﺔ ﺍﻟﺘﻲ ﺘﺅﻜﺩ ﺍﻨﺘﺸﺎﺭ ﺍﻟﻤﻌﻠﻭﻤﺔ ﻻﻨﺘﻘﺎل ﺨﻤﺔ ﻨﻘﺹ  ﺃﻭﺼﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺍﻟﻭﺴ    
ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺭﻴﺔ ، ﺍﻟﻭﻗﺎﻴﺔ ﻭﺍﻟﻤﻜﺎﻓﺤﺔ ﻤﻊ ﺘﻜﺜﻴﻑ ﺍﻟﺠﻬﻭﺩ ﻭﺍﻟﺘﻘﺼﻲ ﻋﻥ ﻭﺠﻭﺩ ﻓﻴﺭﻭﺱ ﻨﻘﺹ 
 .ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺭﻴﺔ ﻟﻜل ﻤﺭﻀﻰ ﺍﻟﺩﺭﻥ 
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INTRODUCTION 
     Despite two World Wars, depressions & epidemics, nothing in the past 
century and till now has affected the lives and the life expectancy of people as 
greatly as the HIV/AIDS epidemic.  
The acquired immuno-deficiency  syndrome  (AIDS)  epidemic  was  first  
recognized in 1981 amongst young gay  men  in  New –York and has since 
become a major world wide epidemic.(1) An estimated 39.4 million people are 
living now with the virus. (2)  
The disease is caused by the human immune deficiency virus (HIV) which 
belongs to the lentivirus group of retroviruses family.   
Researchers had identified 2 serotypes of “HIV”, HIV1 which is the 
predominant sero-type world wide & HIV11, which occurs most commonly in 
West Africa although there is evidence of some spread to the Indian 
subcontinent. (3, 4) 
They both cause AIDS and the routes of transmission are the same; however, 
HIV11 transmission is slightly less easy & may cause slower progression to 
AIDS while HIV1 is more virulent. (3, 4) 
Despite the fact that HIV can be isolated from a wide range of body fluids and 
tissues, the majority of infections occur through transmission via semen, 
cervical secretions and blood. (3) 
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The character of the epidemic in different regions of the world has been 
influenced by the relative frequency of each of the routes of transmission.(3) 
The main modes of transmission of HIV are through sexual intercourse, body 
fluids such as blood, or blood products, semen & vaginal secretion, and by 
sharing of needles among drug users and by injections & needle stick injuries. It 
can also be transmitted from mother to child through the placenta or breast 
milk. (3) 
There is no evidence that HIV transmission occurs through everyday contact, 
hugging or kissing, food or drinks or by bites of mosquitoes or other insects.(3) 
The interrelationship between HIV and the host immune system is the basis of 
the pathogenesis of HIV disease. (3, 4)                             
The helper subset of T-Lymphocytes is central to cell mediated immunity. 
These cells carry the CD4 antigen on their surface (CD4+lymphocytes).HIV 
recognizes the CD4 antigen, and enters and infects the CD4+lymphocytes. 
The result is killing of many CD4+lymphocytes and poor function of the 
survivors.  
Progressive HIV infection therefore causes progressive decline in immunity. 
HIV is also attracted to monocytes & macrophages but it does not destroy them 
in the same way as it does the CD4 cells. Instead it hides in them and is carried 
to the brain, lungs and other parts of the body. (3, 4) 
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 HIV infected persons develop antibodies to HIV antigen usually 6 weeks, but 
up to 3 months, after infection. This “serconvertion” is when a person recently 
infected with HIV first tests sero-positive.This period is called the window 
period and it is usually silent both clinically and serologically. Some people 
have a "glandular fever"-like illness (fever, rash, arthralgia and 
lymphadenopathy) at the time of serconvertion. 
As the HIV infection progresses, the CD4 count falls and the viral load rise. 
Patients become more susceptible to infections such as tuberculosis, septicemia, 
pneumonia and recurrent fungal infections of the skin & oropharynx. Patients 
may develop AIDS related complexes i.e. unexplained fever and weight loss or 
may develop chronic diarrhea with weight loss. (3, 4) With severe 
immunosupression certain specific HIV related opportunistic infections occur 
e.g. cryptococal meningitis and certain tumors as Kaposi sarcoma. In adults 
there is a long, variable latent period from HIV infection to the onset of HIV 
related diseases & AIDS. A person infected with HIV may be asymptomatic for 
up to 10 years or more. Almost all (if not all) HIV-infected people will 
ultimately develop HIV related disease and AIDS. (4) 
Worldwide the main burden of the disease in people living with HIV (PLWH) 
arises from a limited number of common infections and their complications to 
which PLWH are particularly susceptible namely pneumonia, diarrhea and 
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candida infections of the mouth and throat and tuberculosis (TB) which is the 
single bigger killer of PLWH. (5) 
Tuberculosis (simply called TB) is an infectious disease primarily caused by 
mycobacterium tuberculosis. It affects mainly the lungs (pulmonary TB) but it 
can attack any part of the body (extra pulmonary TB). (5)  
Like the common cold, it spreads through the air. Only people who are sick 
with pulmonary TB are infectious. (5) 
Nevertheless tuberculosis is not considered easily transmittable because 
infection generally occurs from close contact with someone with TB disease for 
a long period of time. (5) 
It is important to understand that there is a difference between being infected 
with TB bacilli and having TB disease. (5) 
Someone who is infected with TB bacilli has the TB bacteria in his/her body, 
but the immune system protects him /her from developing the disease. (5) 
Any one can get TB. It strikes people of all races, ages and income levels. 
The following factors are associated with a high risk of becoming infected: 
o Close contact with people with active TB disease 
o HIV infection 
o Poverty 
o Malnutrition 
o Homelessness 
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The risk of developing active disease is mainly related to the immune defense 
of the host. Some conditions such as HIV/AIDS can severely impair the 
immune system, thus facilitating development of the disease. (5) 
   
Justifications  
In Sudan there is no accurate estimate of HIV/AIDS and this is due to: 
• Some people may never seek hospital care for AIDS. 
• Diagnosis of AIDS may not be recorded because of the stigma attached 
to it. 
• Some people with HIV infection may die of other diseases before they 
are ever diagnosed as having HIV. 
• Some rural health care facilities are not equipped for HIV testing. (6) 
Developing reliable estimates of the size of the population at high risk for HIV 
can be grouped into two major areas: policy and programming. 
Policy encompasses:             
                                -  Advocacy 
                                -  Response planning 
                                -  Resources allocation 
                                -  Estimation of numbers infected with HIV & projections  
                                   of the burden of disease and its impact on TB patients 
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Programming encompasses: 
                                 -  Intervention planning. 
                                 - Management of coverage, monitoring and evaluation of  
                                   interventions 
• Such surveys function as an early warning system, alerting policy makers 
and programs managers to emerging risks or changes in existing risk 
behavior. 
• Help identify populations whose behavior makes them particularly 
vulnerable to HIV and to prioritize their needs. 
• Provide data on specific target groups and subgroups as TB patients that 
complements information from general population surveys and for better 
understanding of the dynamics of the growing epidemic. 
• Tackling HIV means tackling TB as the single biggest killer of PLWH 
and tackling TB means tackling HIV as the most potent force driving the 
TB epidemic. 
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LITERATURE REVIEW 
1.1 The Origins of HIV& AIDS 
Debate around the origin of AIDS has sparked considerable interest and 
controversy since the beginning of the epidemic. 
Knowledge of how the AIDS epidemic emerged could be important in both 
mapping the future course of the epidemic and developing effective education 
and prevention programmes (7). 
There is now clear evidence that the disease AIDS is caused by the human 
immuno- virus (HIV), so to find the source of AIDS we need to look for the 
origin of HIV (7). 
HIV is part of a family or group of viruses called lentiviruses. Lentiviruses 
other than HIV have been found in a wide range of nonhuman primates. These 
other lentiviruses are known collectively as simian (monkey) viruses (SIV). It is 
now generally accepted that HIV is a descendant of the (SIV) and many people 
now assume that because, HIV has apparently developed from a form of SIV 
found in a type of chimpanzee in West Africa, it was actually in West Africa 
that HIV first emerged in humans. It is then presumed that HIV spread from 
there around the world. It would be difficult to know exactly when and where 
the virus first emerged, but what is clear that sometime in the middle of the 20th 
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century, HIV infection in humans developed into the epidemic of disease 
around the world that we now refer to as AIDS (7, 8, 9, 10, 11) 
There are a number of factors that may have contributed to the sudden spread of 
the epidemic and these include: international travel, blood industry and 
widespread use of drugs (7, 8, 9, 10, 11). 
1.2 The History of HIV/ AIDS  
The dominant feature in the first period (Mid 1970’s -1980) was silence, for the 
human HIV was unknown and transmission was not accompanied by signs or 
symptoms salient enough to be noticed (12). 
Available data suggest that the current pandemic started in the mid –to late 
1970s. By 1980, HIV has spread to at least five continents (North America, 
South America, Europe, Africa and Australia) (12).                                                   
In 1981 the AIDS epidemic was first recognized when Kaposi’s sarcoma which 
was a rare form of relatively benign cancer that tended to occur in older people, 
occurred amongst gay men in New-York, beside other opportunistic infections 
as pneumocystis cranii pneumonia (1, 13). 
    The disease had several names but the term AIDS was officially adopted in 
August 1982 (14). 
In December 1982 CDC reported a case of infection through blood transfusion 
and also the first cases of possible mother to child transmission of AIDS (15, 16). 
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By the beginning of 1983, it was reported that the disease could be passed 
heterosexually from men to women (17).  
In May 1983, the causative virus has been isolated at the Institute Pasteur in 
France and few months later the virus was named lymphadenopathy-associated 
virus or LAV (18, 19).  
On April 23rd, 1984 Dr Robert Gallo of the National Cancer Institute had 
isolated the virus and it was called the human T-cell lymphotropic virus type 
111(HTLV- 111) (20).  
By March 1985 it was clear that LAV & HTLV-111 viruses were the same and 
the first blood test for AIDS was licensed by the USA Food and Drug 
Administration (FDA) (21, 22) 
In May 1986 the International Committee on Taxonomy of Viruses ruled out 
that both names should be dropped & replaced by a new name HIV. (23) 
Soon researchers identified the two types of HIV i.e. HIV1 & HIV11.  (4) 
The strains of HIV1 can be classified into three groups: “major” group M, 
“outlier” group O and the “new” group N. 
Group O appears to be restricted to West-Central Africa, group N is extremely 
rare and was discovered in 1998 in the Cameroon while 90% of HIV1  
infections belong to group M, within which there are known to be at least nine 
genetically distinct subtypes which are A, B, C, D, F, G, H, J and K. 
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These classifications are of importance in the identification of new strains as 
these types continue to recombine and mutate and spread to new areas as the 
global epidemic continues. (24, 25)  
 
1.3 Symptoms of HIV Infection 
There are no ‘set’ of symptoms for HIV infection or AIDS .Most people who 
become infected with HIV do not notice they have been infected although some 
may suffer from a flu-like illness shortly after infection. (24, 25) 
People who have HIV may feel and look completely well but their immune 
systems may nevertheless be damaged. It is important to note that once 
someone is infected they can pass HIV on, even if they feel well. The more time 
passes, the more likely damage is to have occurred to the immune system. Once 
the immune system is compromised, the person may be susceptible to 
‘opportunistic infections’. These are infections that are around us all the time 
and can normally be fought off by a healthy immune system. Also, some tumors 
or cancers can occur as a result of a damaged immune system and can cause 
damage to the brain and nervous system. These ‘symptoms’ are, however, not 
caused by HIV but by the opportunistic infections. Therefore, there are no 
symptoms of AIDS or HIV as such, until the immune system is so damaged that 
other infections begin to cause health problems which become increasingly 
 24
difficult to treat. So the only way to know if a person is infected is to have an 
HIV antibody test. (24, 25) 
 
1.4 HIV /AIDS Stigma and Discrimination 
From the moment scientists identified HIV and AIDS, social responses of fear, 
denial, stigma and discrimination have accompanied the epidemic. 
Discrimination has spread rapidly, fuelling anxiety and prejudice against the 
affected individuals. It goes without saying that HIV and AIDS are as much 
about social phenomena as they are about biological and medical concerns. 
Across the world the global epidemic of HIV/AIDS has shown itself capable of 
triggering responses of compassion, solidarity and support, but the disease is 
also associated with stigma, repression and rejection of affected individuals by 
their families and communities. (2, 26, 27, 28) 
  Factors which contribute to HIV/AIDS-related stigma: 
• HIV/AIDS is a life-threatening disease. 
• People are scared of contracting HIV. 
• The disease’s association with behaviors (such as sex between men 
and injecting drug -use) that are already stigmatized in many 
societies. 
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• People living with HIV/AIDS are often thought of as being 
responsible for becoming infected. 
From early days in the AIDS epidemic a series of powerful images were used 
that reinforced and legitimized stigmatization. 
• HIV/AIDS is considered as punishment e.g. for immoral behavior, 
a crime e.g. in relation to innocent and guilty victims, a war e.g. in 
relation to a virus which need to be fought, and as horror e.g. in which infected 
people are demonized and feared.  
 These stereotypes also enable some people to deny that they personally are 
likely to be infected or affected. (2, 26, 27, 28) 
On top, with the fuelling of TB epidemics, the real or supposed contagiousness 
of the disease has resulted in the isolation and exclusion of infected people. (2) 
 
1.5 HIV/AIDS Surveillance 
Surveillance is “an ongoing system for collecting information needed for 
advocating, designing, planning and evaluating public health action”. The 
overall objective of any communicable disease surveillance is to collect, 
analyze and disseminate accurate epidemiological data. (29, 30) 
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Surveillance should contribute to a better understanding of the magnitude of the 
problem and provide reliable, timely and cost-effective information for action. 
(30) 
HIV/AIDS is targeted for reduced incidence, prevalence and transmission. 
Control measures are based on prevention and care strategies. Surveillance is 
necessary to assess national needs in education, supplies, and health care and to 
anticipate spread in the community. (31) 
Surveillance will provide epidemiological data used for national prevention and 
care plans and will be essential to evaluate the impact of control activities. (31) 
Surveillance of HIV among TB patients is being increasingly recognized as 
being important, as the HIV epidemic continues to fuel the global TB epidemic. 
In many countries, HIV prevalence in TB patients is a sensitive indicator of the 
spread of HIV into the general population. Information on HIV levels in TB 
patients is essential to respond to the increasing commitment to provide 
comprehensive HIV/AIDS care and support, including antiretroviral therapy 
(ART) to HIV-positive TB patients. (32) 
WHO’s “3 by 5” initiative, to reach 3 million HIV- infected people with 
antiretroviral therapy by the end of the year 2005, will further increase demand 
for HIV testing among TB patients and for knowing the size of HIV associated 
TB. (32) 
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HIV testing is the entry point for ART delivery, and this applies equally to 
patients with TB. Reliable HIV surveillance systems for TB patients and large -
scale access to HIV testing and counseling services are cornerstones for 
effective TB/HIV programmes collaboration. (32) 
At all levels of an HIV epidemic (low-level, concentrated, generalized), routine 
HIV testing data, when available, should be used for surveillance purposes. 
These data can be calibrated by periodic (special) or sentinel surveys. In 
countries where HIV prevalence among TB patients is unknown, a 
seroprevalence survey should be undertaken as part of the initial assessment of 
the situation. (32) 
There are three main methods for HIV surveillance among TB patients: 
     -Data from routine testing of TB patients for HIV  
     -Sentinel surveillance 
     -Periodic (special) surveys. (32) 
 
1.5.1 Linking behavioral data with HIV serosurveillance 
Because the relationship between HIV incidence and prevalence grows 
increasingly complex as the epidemic matures, UNAIDS and its partners are 
promoting the strengthening and development of existing sentinel surveillance 
systems into “second generation” surveillance system, in which behavioral data 
collection becomes an integral component. Second generation system focuses 
 28
more closely on the segments of the general population where most new 
infections are concentrated. (33) 
In any system collecting sensitive data, such as information on serostatus or 
information on sexual or drug-related risk behaviors, steps must be taken to 
minimize biases. For this reason, serosurveillance is usually conducted using 
unlinked anonymous blood samples. This approach reduces the bias introduced 
when people are asked to give a blood sample for HIV testing and refuse. 
Similarly if one selects a sample to answer questions on sexual and drug –using 
behaviors, some of them are likely to decline to be interviewed. Should one ask 
for both a blood sample and an interview on risk behavior, especially from 
women, the combined refusal rate could prove quite high. (33) 
Thus in order to minimize biases, avoid jeopardizing the validity of the 
serological data, and gather less biased behavioral data on the population as a 
whole, it is usually recommended that blood samples and risk behavior 
interviews be obtained from different individuals. But in order to establish a 
clear association between behavior and HIV prevalence in the community, the 
data on HIV serostatus and behavior have to be drawn from the same source. (33) 
 1.5.2 Overview of HIV testing in HIV sero-surveillance 
 HIV testing can be conducted for surveillance, diagnosis, and blood screening. 
Specimens used in HIV testing include whole blood, serum, plasma, urine and 
oral fluids. (34) 
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HIV testing technologies can currently identify: 
• Antibodies to HIV e.g. EIA (Enzyme Immuno Assay), rapid test, 
Western blot, immunoflorescence assay and particle agglutination. 
• Specific HIV antigens (e.g. EIA, antigen testing) 
• HIV viral nucleic acid(e.g. by polymerase chain reaction or other 
techniques) 
• HIV (by viral culture) 
In most industrialized countries, current diagnostic testing procedures use an 
EIA to screen a specimen, and if it is reactive, the result is confirmed by testing 
the specimen with a Western blot. However, studies have shown that the latest 
generations of EIAs and rapid tests are as reliable for confirmation as Western 
blot. (34) 
 
1.5.3 Overview of HIV behavioral surveillance 
HIV epidemics are complex in any country. They often consist of large 
numbers of sub-epidemics in different populations tied together through 
complex behavioral networks. (35) 
Effective strategic planning for prevention creates demands for behavioral data, 
including consideration of the extent of risk in populations as a whole, as well 
as the respective size of various populations particularly vulnerable to HIV. (35) 
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The levels and forms of risk behavior must be assessed in order to understand 
the potential impact of widespread HIV transmission, monitor large-scale 
changes in behavior, and determine the magnitude of ongoing prevention needs. 
(35) 
Lack of knowledge leads to lack of action or inappropriate action. Despite more 
than two decades of the global HIV pandemic, it is surprising how little we 
actually know about risk behaviors in most countries of the world. Even the 
simplest baseline data for evaluating widespread behavior change in 
populations is often lacking. This makes it difficult to move forward and to 
convince people that what is being done makes a difference, especially when 
they see large numbers of people dying around them. (35) 
A lack of accurate knowledge makes it difficult to mobilize responses and 
demonstrate the impact of programmes, and ultimately provides one more 
excuse for not acting. (35) 
It is essential that the necessary behavioral and epidemiological data are 
collected, that these data are analyzed, and that the findings are understood and 
presented in a clear fashion. Continuing to neglect behaviors will foster 
continued neglect of prevention. (35)      
  So TB patients can provide one of the few epidemiological windows on the 
general population as they are an easily identified group that has a higher 
prevalence of HIV than the general population. (35) 
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1.6 Socio-economic Impact of HIV/AIDS 
AIDS is an extraordinary kind of crisis; it is both an emergency and a long-term 
development issue. 
Despite increased funding, political commitment and progress in expanding 
access to HIV treatment, the AIDS epidemic continues to outpace the global 
response.   
 No region of the world has been spared. The epidemic remains extremely 
dynamic, growing and changing character as the virus exploits new 
opportunities for transmission. (2) 
When AIDS first emerged, no one could have predicted how the epidemic 
would spread across the world and how many millions of lives it would change. 
Already, more than 20 million people around the world have died of AIDS –
related diseases. (36)   
As the world entered the third decade of the AIDS epidemic, the evidence of its 
impact is undeniable. Wherever the epidemic has spread un-checked, it is 
robbing the countries of their resources and capacities on which human security 
& development depends. 
Long standing severe epidemics are plunging millions of people deeper into 
destitution and desperation as their labor power weakens, incomes become less 
and less, assets shrink & households disintegrate. (36) 
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Weakened by AIDS, traditional strategies became unable to cope with further 
threats such as armed conflicts, crop failures or natural disasters. 
In  some  regions HIV/AIDS, in  combination  with  other  crisis, is  driving 
ever larger  parts of nations towards collapse. 
In several countries  experiencing  early  stages  of  the epidemic, significant 
economic  and social changes are giving rise to conditions& trends that favor 
the rapid spread of HIV, for  example  wide social disparities, limited  access  to 
basic services, increased migration & internal displacement and overlapping 
with other diseases, as with the global tuberculosis epidemic. 
In all affected countries with either high or low HIV prevalence, AIDS hinders 
development, exacting a devastating toll on individuals and families. In the 
hardest-hit countries, it is erasing decades of health, economic and social 
progress-reducing life expectancy by years, deepening poverty, and 
contributing to, and exacerbating food shortages. In many countries especially 
in Africa, millions of adults are dying young or in early middle age. Average 
life expectancy in Sub-Saharan Africa for example is now 47 years, when it 
could have been 62 without AIDS. (36) 
The toll of HIV/AIDS on households can be very severe. Many families are 
losing their income earners. Many of those dying have surviving partners who 
are themselves infected and in need of care. 
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In all affected countries, the HIV/AIDS epidemic is bringing additional pressure 
to bear on the health sectors. As the epidemic matures, the demand for care for 
those living with HIV rises, as does the toll amongst health workers. (36) 
How schools and other educational institutions are able to cope is a major factor 
in how well societies will eventually recover from the HIV/AIDS epidemic. A 
decline in schools enrolment is one of the most visible effects of the HIV/AIDS 
epidemic. 
HIV/AIDS dramatically affects labor, setting back economic activity and social 
progress. (36)   
As the  growth  of  the  HIV  pandemic  is  outpacing  the  mobilization  of  
resources, preventive efforts must become more focused, more inclusive of the 
full spectrum of those with risk behavior and more efficient and effective.(37) 
This requires good behavior information, so that resources can be directed to 
where they have the greatest impact & more effective preventive alternatives 
are chosen. 
Knowledge  of  risk  behaviors  for  HIV  still  have  severe  limitations  in  
most  of the countries of the world. (37) 
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GLOBAL SUMMARY OF THE AIDS EPIDEMIC 
DECEMBER 2004 (2) 
 
No. of people living with HIV/AIDS: Total                 39.4 million (35.9-44.3 million) 
in 2004:                                                Adults               37.2 million (33.8-41.7million) 
                                                            Women             17.6 million (16.3-19.5 million) 
                                                            Children<15      2.2 million   (2.0-2.6 million) 
.                                                                                                                                       .    
 
People newly infected with HIV        Total                  4.9 million (4.3-6.4 million) 
 in 2004:                                              Adults                4.3 million (3.7-5.7 million)                               
                                                           Children<15        640 000     (570 000-750 000)         
                            
.                                                                                                                                       .    
AIDS deaths in 2004:                          Total                   3.1million (2.8-3.5 million) 
                                                            Adults                 2.6 million (2.3-2.9 million)                                                 
                                                            Children<15        510,000     (460 000-600 000) 
 
The number of people living with AIDS has been rising in every region, 
compared with two years ago, with the steepest increases occurring in South 
East Asia, and Eastern Europe and Central Asia. The number of people living 
with HIV in South East Asia rose by almost 50% between 2002 and 2004, an 
increase that is attributable largely to China’s swiftly growing epidemic.(2) 
In Eastern Europe and Central Asia, there were 40% more people living with 
HIV in 2004 than in 2002. 
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HIV prevalence in the Caribbean is the second –highest in the world, exceeding 
2% in five countries, and AIDS has become the leading cause of death among 
adults aged 15 -44 in this region. 
 Sub-Saharan Africa remains by far the worst affected region, with 25.4 million 
[23.4 million-28.4 million] people living with HIV at the end of 2004, 
compared to 24.4 million [22.5 million-27.3 million]in 2002.(2) 
Just under two third (64%) of all people living with HIV are in Sub-Saharan 
Africa, and so are more than three quarters (76%) of all women living with 
HIV. 
The epidemics in sub-Saharan Africa appear to be stabilizing generally, with 
HIV prevalence at around 7.4% for the entire region. But such a summary 
perspective hides important aspects. (2) 
First, roughly stable HIV prevalence means more or less equal numbers of 
people are being newly infected with HIV and are dying of AIDS. Beneath the 
apparent constancy of steady prevalence levels lie devastating realities-
especially in Southern Africa, which accounts for one third of all AIDS deaths 
globally.(2) 
Second, the epidemics in Africa are diverse, both in terms of their scale and the 
pace at which they are evolving. There is no single “African” epidemic.(2)      
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 It is projected that by 2020, if HIV spread has not been contained, AIDS will 
increase infant mortality rate by 25% and under 5 mortality by 100% in regions 
mostly affected by AIDS.(38)                                                                                                       
HIV related disease may account for over 75% of annual deaths in the 15-60 
years of age group within the next 15-20 years and life expectancy at age 15 in 
severely affected countries could drop from 50 to below 30 years. (37) 
Concerns that HIV  would continue to strengthen its presence in the Middle 
East and North Africa are borne out by the latest estimates which show that 92 
000 [34 000-350 000] people became infected with HIV in 2004.That brings to 
540 000 [230 000-1.5 million] the total number of people living with the virus 
in this region. AIDS killed an estimated 28000 [12000-72000] people in 
2004.Among young people 15-24 years of age, 0.3%of women [0.1-0.8%] and 
0.1% of men [0.1-0.3%] were living with HIV by the end of 2004. HIV is being 
transmitted along diverse paths in this region, including paid sex, sex between 
men and injecting drug users, and there exists significant scope for further   
expansion of the epidemic.(2) 
 On the other hand TB is wreaking havoc on the world. Approximately 2 billion 
people (one third of the world’s population) are infected with Mycobacterium 
TB. (39) 
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Each year more than 8 million cases of TB and 3 million deaths occur 
worldwide. Someone in the world is newly infected with TB every second and 
someone dies every 15 seconds. (39) 
Overall, one-third of the world’s population is currently infected with the TB 
bacillus. 
5-10% of people who are infected with TB bacilli (but who are not infected 
with HIV) become infectious at some time during their life. (5) 
HIV and TB form a lethal combination, each speeding the other’s progress. 
More than one- third of PLWH worldwide are co-infected with TB and 40-60% 
of them will develop tuberculosis. (5) 
About 2 million TB cases per year occur in Sub-Saharan Africa. 
Around 3 million TB cases per year occur in South-East Asia. 
Over a quarter of a million cases per year occur in Eastern Europe. 
The vast majority of cases (95%) arise in developing countries and 80% of 
incident cases are found in 22 countries with 50% in just 5 South-Asian 
countries. 
About 75% of TB cases occur in people between 15-60 years of age and the 
male female ratio is 1.2-1.5: 1 globally. (40) 
TB is responsible for about 2.8% of the world’s Disability Adjusted Life Years 
(DALYs) burden, similar to that of malaria and lies tenth in the diseases’ global 
burden. (41) 
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 Two million deaths resulted from TB in 2002. As with the cases the highest 
number of estimated deaths is in the South-East Asia Region, but the highest 
mortality per capita is in the Africa Region, where HIV has led to rapid increase 
in the incidence of TB and increases the likelihood of dying from TB. (42) 
It is estimated that between 2002 and 2020, approximately 1000 million people 
will be newly infected, over 150 million people will get sick, and TB will claim 
the lives of 36 million around the world. (42) 
 
1.7 Lethal Combination of HIV and TB 
The relationship between TB and HIV has been recognized since the early days 
of the HIV epidemic.  
Human immunodeficiency virus type 1 (HIV-1) and M.tuberculosis are two 
intercellular pathogens that interact at the population, clinical and cellular 
levels. Initial studies of HIV1 and TB emphasized the impact of HIV1 on the 
natural progression of TB, but mounting immunologic and virologic evidence 
now indicates that the host immune response to M. tuberculosis enhances HIV 
replication and might accelerate the natural progression of HIV infection. (43) 
Studies of immune response in persons with TB disease support the biologic 
plausibility of co- pathogenesis in dually infected persons. (43) 
When TB disease develops in an HIV-infected person, the prognosis is often 
poor, though it depends on the person’s degree of immunosuppression and 
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response to appropriate anti-tuberculosis therapy. The 1-year mortality rate for 
treated, HIV- related tuberculosis ranges from 20-30% and shows little 
variation between cohorts from industrialized and developing countries. The 
observed mortality rate for HIV –infected persons with TB is approximately 
four times greater than the rate for TB patients not infected with HIV. (43) 
Although the cause of death in the initial period of therapy can be TB, death 
after the induction phase of anti-tuberculosis therapy usually is attributed to 
complications of HIV other than TB. (43) 
TB  is the most common opportunistic infection in people living with AIDS and 
it is the first manifestation of AIDS in over 50% of cases in developing 
countries and it is the leading killer of people with AIDS( kills one out of every 
three people with AIDS worldwide).(37) 
A person co-infected with TB and HIV faces a strong risk (up to 30 folds) of 
developing active TB disease. (44) 
 About a third of the PLWH worldwide are co-infected with Mycobacterium 
TB. 
Since 70% of those co- infected live in Sub-Saharan Africa, this region also 
bears  the overwhelming  brunt of  the  global  epidemic of HIV associated  
TB. (38) 
Escalating TB case rates over the past decade in Sub-Saharan Africa are largely 
attributable to the HIV epidemic. (38) 
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HIV has fundamentally altered epidemiology of TB, which becomes reactivated 
in 5-10 % of HIV infected people /year, while 8% of global TB cases are 
attributable to HIV, in Sub-Saharan Africa the figure is 40% (single most 
important factor determining the increased incidence of TB in the past 10 
years).(38)    
HIV testing in several developing countries has shown that as many as 70% of 
smear positive cases are also co-infected with HIV (estimated to be 77% in 
Malawi). But as HIV infection may be undiagnosed in TB patients, the 
researchers suggest that the true figure is likely to be higher. (38) 
HIV is not only fuelling the TB epidemic but is also making TB control more 
challenging. 
            -Increased number of HIV –related TB cases in most countries will  
               represent at least a two-fold increase in total number of TB cases  
              with urban areas being most heavily impacted.(35) 
            -In addition to the effect that the increased burden has on diagnosis, it  
               is also more difficult to diagnose individual cases. Furthermore,   
               HIV causes several other pulmonary problems that may be   
               misdiagnosed as TB and TB programmes are increasingly faced by 
               patients with other medical problems associated with HIV in  
              addition to TB. (35)    
           -Even in programmes that use the DOTs strategy, mortality in HIV+ve   
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              patients is high, mostly from other manifestations of HIV disease.   
              This leads both to loss of the community’s confidence in the 
               programme as  well as to deterioration in staff morale. Adherence to  
               therapy and follow-up may be threatened by other medical and  
                social problems affecting HIV-infected patients.(35) 
              -The association of TB with HIV is widely recognized in  
                 communities bearing the brunt of the dual epidemic and HIV  
                 remains a highly stigmatizing infection. Some patients may choose  
                 not to attend health  facilities through fear of being diagnosed with  
                 TB and by association with HIV infection.(35) 
             - Misconceptions about TB and HIV also lead to some health care 
                workers worrying about the risk of acquiring HIV from their  
                patients. Other staff may discriminate against TB patients,    
                perceiving them to be less deserving for care through association  
                with HIV infection .(35) 
In summary, HIV has adversely affected TB control programmes both directly 
through increases in caseloads and more difficult diagnosis, but also indirectly 
through its effect on health –seeking behavior and the interaction between 
patient and provider at the health services. (35) 
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1.8 The HIV Status in the Sudan 
The  first  case  of  HIV/AIDS  was  diagnosed  in  the  Sudan in 1986 .Since 
then the prevalence of the disease is on the increase .By 1997 about  250  cases  
were  reported and in 1998 the number of cases was 511. In 2000 the number 
was 652 cases. During the period 1986 through 2002, 4820 cases were reported. 
(45)   
HIV has recently grown to become a major health problem in Sudan. Although 
the surveillance  system  is  limited  to  4  sites  only , it  is  feared  that  Sudan  
is facing a generalized epidemic i.e. the epidemic state in which HIV is firmly 
established in the general population(HIV prevalence consistently >1% in 
pregnant women).(2)The  geographic  location  of  the country  with extending 
boarder with other countries some  of  which  with  high  prevalence , played  a  
role  in  the  growing  epidemic  in addition to the high population movement  
in Sudan which is due to:                                                                                    
• Civil wars 
• Natural disasters 
• Economic factors and emigration for work. 
Latest estimates show that more than 2% of the adult populations were 
living with HIV at the end of 2003 and that amounts to more than 80% of all 
people with HIV in the Middle-East Region.(2) 
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? Estimated number of adults and children living with HIV/AIDS by end of 
2003: 
                       ADULTS       (15-49)         380,000 (120 000-1,200,000) 
                       WOMEN       (15-49)          220,000 (66,000-690,000) 
                       CHILDREN   (0-15)             21,000 (6,000-72,000) 
? Estimated number of deaths due to AIDS(adults +children) was 
23,000(8,000-61,000) 
? Estimated number of orphans i.e. children lost father or mother or both 
parents to AIDS and who are alive and under age of 15 at the end of 2001 
was estimated to be 62,000.(2) 
Still wracked by civil wars and humanitarian crises in some regions, Sudan 
remains the worst affected country in the Middle-East Region. (2) 
Previous HIV surveillance data have shown HIV prevalence to be up to eight 
times higher in the South of the country compared with the capital, Khartoum. 
It is also high in the Eastern region to the boarders of Eritrea and Ethiopia due 
to influx of refugees from both countries (prevalence among refugees is 4.6%) 
as well as the major port areas where the trucking routes are.(2) 
In the Khartoum State, the registered cases between 2002 up to September 2004 
were 3319 cases (about 3.8% of 88,000 expected cases in the state).  (46) 
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It is possible that the gradual cessation of conflict in parts of the country could 
accelerate HIV spread, as people resume their normal patterns of travel and 
trade. (2) 
1.8.1Detailed assessment of the epidemiological situation (2002) 
HIV prevalence among pregnant women was reported to be 2.94% in 1997. 
Based on HIV surveillance data in  Khartoum State in 2002, 2.5% of women 
attending gynecology  clinics  were  found  to  be  HIV  seropositive , compared  
to  HIV  sero-positivity rates of 1.86% in pregnant women attending antenatal 
clinics.(45) 
Women attending both gynecological and antenatal clinics in Khartoum State 
showed a curable STI incidence of 10.5% and34 % respectively. (37) 
HIV rates among blood donors increased from 0.15% in1993 to 1.4% in 1999 
&2000 respectively. (45) 
There is a clear link between HIV&TB. In 2002, HIV prevalence among TB 
patients varied between 7.7% and 20% depending on the region. (37) 
Sudan National AIDS Control Programme (SNAP) decided to undertake a 
national survey that could assess the magnitude of HIV/ AIDS in the country 
and provide information about the knowledge, attitude, and the behavior of the 
different sectors of the community. 
Overall prevalence was 1.6% and also 1.6% among TB patients Prevalence 
among women attending the antenatal clinics was 1.0%. Prevalence among the 
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refugees was 4.0% while prevalence of the other high risk groups tested was 
4.4% among prostitutes, 2.5% among tea sellers, 25% of the suspected AIDS 
patients. (47) 
The results of the behavioral survey showed that the majority of the respondents 
(78.6%) heard about AIDS .When asked about the mode of transmission 53.2% 
mentioned sexual intercourse, 29.9% blood transfusion, 26.7% skin penetration 
and 13.4% transmission from mother to child.More than two-thirds never 
saw/heard about condom and only 3.7%of the respondents ever used male 
condom. (47) 
The  HIV/AIDS  epidemic  in the Sudan is  influenced  by  cultural & socio-
economic factors .Similar to several other African countries, the  main  mode  
of  transmission is heterosexual which accounts for 94% of the cases. Data on 
homo-sexual  practices and the  prevalence  of  STIs , which  are  known to 
increase the risk of HIV is very scanty . (2, 47) 
Prenatal transmission does not seem to be a major mode of 
transmission .Testing of blood donated for transfusion is still limited. Practice 
of reusing unsterilized syringes are now very limited. Injecting drugs is not 
widely practiced in the Sudan. (2, 47) 
On  the  other hand  the  estimated  incidence of tuberculosis is high in Sudan 
which is the third among the 9  high  TB  burden  countries  in  the  East-
Mediterranean  region after Pakistan  and Afghanistan and the 24th on the 
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Global rank with an estimated incidence of 217/100000 population (for all 
cases/100,000 pop.) . (5, 48)                                                     
HIV sentinel sites surveillance among TB patients showed gradual increase in 
these sites since 1991. 
                                  Khartoum          Port Sudan           Medani            Juba          
  April      1991                0%                    0%                     0%              14%     (49) 
  October 1991                0.5%                 0%                     0%               16.2 %( 50) 
                1992               0%                    0.5%                  1.6%              0%      (51) 
December 1993               2.6%                   _                        _                13.6%   (52) 
December 1994               2.8%                   _                        _                 20%     (53) 
                 1997              9.8%                   _                        _                  _                (54)      
                 1999              7.2%                   _                        _                  _                (55) 
                 2000              8.1%                   _                        _                  _                (56) 
                 2002              7.7% - 20%     according to   the regions. (37) 
                 2004              2.81% (46) 
1.9 Review of Previous Studies 
-In the United States of America, the Center for Disease Control (CDC), in 
collaboration with state and local health departments, initiated HIV surveillance 
of patients with confirmed and suspected TB in clinics and hospitals in the 
United States. Blinded (serologic results not linked to identifiable persons). 
HIV seroprevalence surveys were conducted in sentinel TB clinics and 
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hospitals that provide TB clinical services each year, to obtain estimates of the 
level of HIV infection in TB patients and to follow the trends in infection over 
time. Non-blinded (voluntary) surveys were also conducted to evaluate 
behaviors that have placed TB patients at risk for or protected them against HIV 
infection. Data from these surveys were used to target education and prevention 
and control programs for TB and HIV infections and to monitor changes in 
behavior in response to such programs. (57) 
-In the Cameroon a study was carried out to asses whether the HIV 
seroprevalence rate in adults with smear-positive pulmonary tuberculosis can 
serve as a sentinel group for the estimation of HIV prevalence in the adult 
population. 
A systematic review of reported HIV seroprevalence rates in the general adult 
population and in adults aged 15 years and over with pulmonary TB (PTB) in 
Cameroon, was carried out using indexed articles, publications, and reports 
from 1989 to 2000. Reconstruction of the evolution of the HIV seroprevalence 
in the two populations was done and the relationship between these, was 
established by the regression equation and the calculation of the correlation 
coefficient r. 
Results revealed that during the period1989-2000, the evolution of HIV 
seroprevalence in the general adult population and in adults with PTB showed a 
steady increase, with a strong linear relationship ( r = 0.96, df 7, p<0.01) Each 
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percentage increase of HIV seroprevalence among PTB patients correspond to 
an increase of about 0.3% in the general population. 
The study came with a conclusion that HIV seroprevalence in PTB patients in 
Cameroon could serve as a ‘sentinel’ for seroprevalence in the general 
population. (58)   
Several studies around the world have been done to estimate the HIV 
seroprevalence in tuberculous patients in different health care settings. 
-A cross sectional study of adult tuberculosis patients admitted into the DOTs 
programme of the TB and leprosy control center in Olabisi Onabanjo University 
Teaching Hospital, Sagamu, Nigeria, between January 2001 and December 
2002 was undertaken. Data was collected using interviewer -administered 
questionnaire. HIV screening was carried out for all patients. 
Results showed that out of the 269 cases of PTB registered at the clinic, 40 
(14.9%) were HIV sero-positive. The peak age prevalence was in the third 
decade accounting for 42.5% of cases, followed by 32.5% in the second 
decade. (59) 
-In Mozambique the rate of HIV seoprevalence among tuberculosis patients 
varies between 2% and 53% according to the region. So a study was carried out 
to estimate the HIV seroprevalence in patients with PTB. All tuberculosis 
patients diagnosed at randomly selected health facilities in the period 
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September 1998 to June 1999 were enrolled in the study. Results revealed that 
25.5% of the 709 culture positive cases were also HIV positive. (60) 
 
-In Chad a sero-behavioral survey was done to evaluate the HIV 
seroprevalence, epidemiological characteristics and risk factors in patients with 
tuberculosis. 
A total of 466 patients were included in the six-month period between January 
and June 1999. Each subject was to respond to an anonymous standardized 
questionnaire with detailed information about demographic characteristics, 
sexual behavior and other risk factors for HIV infection. 
One third (33.2%) of patients were found to be HIV positive. Median age was 
31.1 years. Median Age for first sex was 16.3 years.  Sero-positive women were 
more than men (39.5 %versus30.1%) and sero-positives were also more likely 
to have multiple sexual partners. (61) 
-In the Central Chest Hospital in Bangkok, Thailand, a study was conducted to 
determine HIV seroprevalence among patients with pulmonary TB. 
Out of the 2587 newly registered patients with suspected TB, 2019(78%) 
received HIV pretest counseling and 1816(90%) consented to testing. Of these, 
364(20%) were HIV positive. Among patients with bacteriologically confirmed 
TB, the prevalence was 22%. (62)     
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-In Vietnam the spread of HIV infection was thought to be limited. In 12 urban 
districts of Ho Chi Minh City, representative samples of tuberculosis patients 
had undergone HIV testing since 1995. HIV prevalence increased steeply from 
0.5% in 1995 to 4% in 2000, with a doubling time of approximately 21 months. 
(63) 
-In Japan the number of patients co-infected with HIV and TB in hospitals was 
found to be increasing year after year. In order to determine the HIV sero-
positivity among TB patients, HIV testing was carried out in TB patients for 
two years starting from January 1998 with the consent of patients. TB patients 
who received anti- HIV antibody testing were 164 in 1998 and 149 in 1999 and 
among them HIV sero-positive TB patients were 4 in 1998 and 6 in 1999. The 
incidence of HIV sero-positivity was 3.2% in all TB patients 28.6% in milliary 
TB patients, and 1.0% in pulmonary TB patients. (64) 
 
-In the North district of Tamil Nadu in India, a study was undertaken in four 
centers: District Tuberculosis Center (DTC) (Vellore), Tuberculosis Sanatorium 
(Pennathur), District TB Center (Kancheepuram), and the Government 
Thiruvotteswarar Tuberculosis Hospital (GTTH) during 1997-1998. A total of 
2361 newly diagnosed TB patients were registered in that study. HIV serology 
after pre-test counseling was done.  
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The overall HIV sero-prevalence was 4.7%.The highest HIV sero-positivity rate 
was found among patients aged 30-39 yr (10.6%). HIV sero-prevalence showed 
a wide variation among the different centers ranging from 0.6% in DTC 
(Kancheepuram) to 9.4% in Pennathur Sanatorium. (65) 
-In a hospital for tertiary care in North India between 2000 and 2002, out of 555 
patients with various forms of tuberculosis, 52 were found to be sero-positive 
(9.4%) 
In 1999, the HIV sero-positivity was only 0.4%. This dramatic increase 
highlighted the importance of continued HIV sero-surveillance in TB patients. 
(66) 
 
-A study carried out in Jakarta, Indonesia investigated the demographic and 
high risk behavior characteristics among recently diagnosed pulmonary 
tuberculosis patients aged 18-40 years. Three hundred and four participants 
were recruited voluntarily from two general hospitals. 38.5% were unemployed, 
69.7% were in low socio-economic condition. About 8% had received a 
transfusion, 3.2% of the males admitted to being homosexuals, (35.5% of 
males, 4% of females) engaged in extramarital heterosexual relations and 3.6% 
of participants had one or more symptom of sexually transmitted disease. (67)  
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-Since the mid-1980s the number of TB cases notified within the United 
Kingdom has continued to rise although the contribution of HIV to that was not 
known. So a study was carried at chest and HIV clinics in 4 hospitals in 
Lambeth, Southwark and Lewisham (LSL), an area of South London, to 
determine proportion of patients with culture-proven TB, infected with HIV and 
to identify risk factors for the co-infection. 
Demographic data and blood samples were collected, anonymised and HIV 
tested. 
Out of 159 patients enrolled in that study 21 patients were HIV positive (13%) 
and were significantly more likely to be in the age range between 35 and 55 
years. (68) 
-Another study was also conducted in South London. All patients with 
tuberculosis and their contacts were anonymously tested for HIV in blood and 
saliva. 
11.4% of TB patients and 5% of their contacts were HIV positive.(69) 
- Latvia in the Baltic region experienced a 58-fold increase in HIV 
seroprevalence among persons tested in the country from 1996 through 2001. In 
addition HIV sero-prevalence among TB patients was estimated and was found 
that it increased from 0% to 5.6% from 1998 through 2001. (70) 
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-In Los Angeles County, a study was carried out during 1993-1996.The study 
aimed to describe the prevalence and risk factors for HIV among persons with 
newly diagnosed, class 111 (confirmed) and class V (suspected) cases of 
tuberculosis. 
HIV testing was performed on 1307 blood specimens at 6 TB clinics. 
HIV test results were matched to demographic and risk behavior information 
making use of an unlinked study methodology. 
The results were as follows:- 
-Overall rate was 10.8% 
-Risk behaviors included injection of non prescription drugs, having sex with an 
injection drug user, use of non-injection forms of heroine, cocaine and 
tranquillizers. Homosexual men were more likely to be HIV infected than 
heterosexual males. (71)                                               
 
 
 
 
 
 
 
 
 
 
 
 54
OBJECTIVES 
 General Objective: 
   To determine HIV seroprevalence and risk behaviors in patients with  
    tuberculosis attending TB diagnostic clinics in Khartoum State (2004). 
Specific Objectives: 
1. To determine the seroprevalence of HIV in adult tuberculous patients 
     (16- 60) years old. 
     attending the TB diagnostic clinics in health facilities in Khartoum State. 
2. To identify risky behaviors associated with HIV infection including: 
     -sexual practices. 
     -blood transfusion. 
     -history of surgical operations. 
     -sharing of syringes and razors  
3. To determine the knowledge, attitudes and practices about HIV/AIDS and  
     reveal gaps that can be addressed by interventions.   
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MATERIALS AND METHODS 
2.1 Study Design 
This is a descriptive cross sectional health facility based study. 
2.2 Study Area 
Khartoum State is the study area. The ongoing programmes, laboratory 
facilities and presence of organized health facilities made it the state of choice. 
The state is the Capital of Sudan; it lies between latitudes 15.10-16.30 degrees 
north and 31.35-20 degrees east in the center of the Sudan, with an area of 
28,000 km², a total population of about 5,302,000 million and growth rate of 
about 4.04 % .The urban population constitute about 85 % of the total 
inhabitants.(72) 
Due to the war in the South and Western Region, draught and difficult 
economical situations, the peripheries of the state are inhabited by immigrants 
and displaced people.     
The Nile and its tributaries divide the state into 3 geographical areas:   
 - Khartoum 
 -Umdurman 
 - Khartoum North 
These  areas  are  further  subdivided  into  seven  provinces  and  35  
administrative localities.  
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Expected number of cases of tuberculosis in the state is about 9000 cases with 
an incidence rate of 188/100000 population. There are about 31 health centers 
and hospitals which provide Directly Observed Therapy for TB (DOTs 
Centers). (73) 
The study was carried out in health facilities chosen according to the following 
criteria: 
 
2.2.1 Inclusion criteria 
Any health facility in the Khartoum State which fulfilled the following criteria 
was included: 
1-Being a TB diagnostic health facility. 
2-The facility delivers the Directly Observed Therapy services i.e. DOTs 
centers 
3-Number of patients registered at the facility is more than 20. 
 
2.2.2Exclusion criteria 
Any health facility which did not fulfill the above mentioned criteria. 
 
2.3 Study Population 
Only adult patients (16-60 years old) with confirmed TB infection will be 
enrolled in the study. 
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2.3.1 Case definition 
Smear –positive pulmonary TB: 
TB in a patient with at least 2 initial smears examinations +ve by direct   
microscopy for acid -fast bacilli.                                                                                        
Or 
TB in a patient with one initial smear examination +ve by direct microscopy 
and +ve by culture. 
Or 
 TB in a patient with one initial smear examination +ve by direct microscopy 
for AFB  and  x-ray  abnormalities  suggestive  of  active  TB  as  determined  
by  a Physician. 
Smear –negative pulmonary TB:- 
TB in a patient with three initial negative smear examinations by direct 
microscopy for AFB and who has failed to respond to a course of a broad 
spectrum antibiotics, and again 3 –ve smear examinations by direct microscopy, 
and x-ray suggestive of active TB as determined by the physician. 
Or 
TB in a patient with three initial smear examinations –ve by direct microscopy 
but +ve by culture. 
 
Or 
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TB in organs other than the lungs proved by one culture– positive specimen 
from an extra –pulmonary site or histo-pathological evidence from a biopsy.75 
2.4 Sample 
2.4.1 Sample frame 
An adult (16-60 years old) with confirmed TB who attends a health center 
which provides DOTs services. 
2.4.2 Sample size 
n =   z ² pq × 2 
           d2 
Where 
n = sample size 
z =statistical certainty 
p =prevalence of HIV among TB patients 
q =1-p 
d =desired margin of error 
=1.96² ×0.016 .0.984 × 2   = 302 patients 
                  0.02² 
302 patients were interviewed and sero-surveillance was carried out for another 
302 patients. The two surveys were conducted on the same health facilities but 
on different days.   
2.4.3 Sampling technique 
 59
Simple random sampling using probability proportional to size technique was 
applied. 
Seven health facilities were selected according to the inclusion criteria, with a 
total number of about 322 attending patients. 
Number of patients within each facility is calculated by using probability 
proportional to size and then they were selected randomly. 
Number of patients in each facility was calculated as follows: 
Haj Alsafi health center                       20 × 302 = 19 patients 
                                                                 322 
Alrakhaa health center                        21× 302 = 20 patients 
                                                               322 
Id Hussein (Alshaheed Alkalas)           28× 302 = 26 patients 
Health center                                           322   
Ibrahim Malik Hospital                        61× 302 = 57 patients 
                                                                 322 
Abu Sieid health center                       40 × 302 = 38 patients         
                                                                322 
Khartoum Bahry Hospital                    60 × 302 = 56 patients 
                                                                  322 
 Abu Anja Hospital                             92 × 302 = 86 patients    
                                                                 322 
Total                                                                   = 302patients 
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2.5 Tools of Data Collection 
2.5.1 Questionnaire 
Structured close- ended pre-tested questionnaire for the behavioral survey was 
used. (Appendix1). 
     It consisted of six sections concerned with the following:       
• Socio demographic background of the respondent. 
• Awareness about HIV/AIDS mode of transmission and prevention. 
• Recognition and use of condoms. 
• History of sexually transmitted disease infection. 
• Available and accessible mass communication channels in the local area. 
• The history of TB disease and drug history.  
The questionnaire was translated from the Family Health International 
questionnaire and back translated for the sake of data entry and analysis. 
The survey was conducted by a team which consisted of six data collectors 
in addition to the supervisor. 
The data collectors were trained for three days and were given sessions on:  
   -the behavioral survey and its objectives 
   -How to proceed with the survey: step by step 
   -Questionnaire: Role play  
Then the questionnaire was tested on the field before the start of the survey.   
2.5.2 HIV serological test. 
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The HIV test was not done for the same patients who responded to the 
questionnaire in compliance with the Second Generation Surveillance 
Guidelines. (33) 
Enzyme Immunoassay (EIA) test is used for screening blood specimens. Those 
specimens which were found to be reactive were confirmed by another EIA test 
of different formatting. 
Unlinked anonymous testing (with confirmed consent) was performed. (34)  
Blood was the preferred specimen for testing because it has a higher 
concentration of HIV antibodies than urine or oral fluids. (34) 
For safety reasons an evacuated blood collection system is used. Blood was 
collected in pre-coded red-top vacutainers (without anticoagulant).   
5 ml of blood were collected from the patient’s vein after tying a tourniquet. 
Samples were stored in a cold box containing ice packs and were transported 
immediately to the National Health Laboratory.  
Third generation EIAs were used for screening the samples. These were a solid-
phase enzyme immunoassay for the detection of antibodies to HIV in human 
serum or plasma, manufactured by Ani Labsystems with 100% sensitivity and 
99.5% specifity. 
Specimens found to be positive by the screening test were confirmed by another 
third generation EIA test with different formatting. It is called Anti-HIV Tetra 
Elisa test for the qualitative determination of Anti-HIV antibodies in human 
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serum or plasma, manufactured by Biotest Company with 100% sensitivity and 
99.83% specifity. 
Principles of the test:   
• The whole blood specimens were centrifuged to obtain the serum. 
• The specimen serum is diluted in the specimen buffer and put in a micro 
well plate containing HIV antigen already bound to the plate. 
• The plates were incubated as per protocol and then washed. 
• Anti-human immunoglobulin-enzyme conjugate was added to react with 
the HIV specific antibody, if present. 
• Wells were incubated and washed again and a colourless enzyme 
substrate and chromogen were added and incubated once more. 
• The enzyme reaction of chromogen/substrate produces a coloured end 
product. 
• The enzyme reaction was terminated by an acid (H2SO4). 
• The absorbance of the solution was read in a spectrophotometer. 
• A positive reaction has occurred if the specimen well changes colour or 
becomes coloured, which indicates the presence of HIV-specific 
antibodies. (34)   
Positive results were presented in a sheet with their code numbers. 
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 2.6 Data Management and Statistical Analysis 
Questionnaire data was transferred to master sheets and entered into the 
computer and analyzed by the Statistical Package for Social Science computer 
programme (SPSS). 
Chi-square tests were used for the behavioral survey and results were 
considered significant at P<0.05. 
Bivariate analysis was used for the Epidemiological survey. 
2.6.1 Data presentation 
Data is presented in form of tables, pie charts and bar charts. 
 2.7 Limitation of the Study 
As unlinked anonymous blood testing was performed, positive patients were not 
identified and so were not offered counseling or treatment. 
2.8. Ethical Considerations 
Ethical approval and clearance certificate for the study was obtained from the 
Ethical Review Committee, Federal Ministry of Health. (Appendix 2) 
 
 
 
 
 
 
 64
RESULTS 
 
3.1 Epidemiological Survey 
 
 Median age of patients was 31 years. Gender ratio between males and females 
was 2.5:1 i.e. 215 (71.2%) males and 87 (28.8%) females. 
Twenty–three patients (7.6%) (mean=0.08, confidence limits=0.05→0.11) were 
found to be positive for the HIV test (scanned and confirmed). 18 (78.3%) of 
them were males and 5 (21.7%) were females. 
Bivariate analysis showed that age and gender of the patients were not 
correlated with HIV infection. (age and gender did not affect the susceptibility 
of the TB patients to get HIV infection) 
3.2 Behavioral Survey 
3.2.1 Sociodemographic profile 
 
 The median age of the respondents was also 31 years. Gender ratio between 
males and females was 1.8:1 i.e. 193 (63.9%) of the patients were males and 
109 (36.1%) were females.    
The distribution of the patients according to their occupations was as follows: 
21(7%) were students, 6(2%) were teachers, 46 (15%) were laborers, 9 (3%) 
were civil servants, 69 (22.8%) were self-employed, 24 (7.9%) were farmers, 7 
(2.3%) were military personnel, 25 (8.3%) were housewives, 5(1.7%) were 
retired and 90 (29.8%) were unemployed. (Fig 1) 
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Figure 2 Shows that (6%) of the respondents were divorced, (5%) widowed, 
(35%) were not married and (54%) were married. Of those who were married 
(19 %) were in polygamous marriages and (46%) had only one wife or husband 
(Fig. 3) 
About 59% of the participants can read and write while 41.1% of them were 
illiterate. 
Fourteen percent and 1.1% of the patients had Khalwa, and Pre-school 
education respectively. Those who had Basic education were 32%, Intermediate 
9%, Secondary school education 29.2%, and only 14% of them had reached the 
university level and 0.6% had Post-graduate studies. (Fig. 4). 
Figure (5) shows that (12.9%) were born in Khartoum, (15.9%) in Alwasat 
Region, (48.7%) in the West, (5.3%) in the East, (4%) in the North, and (9.9%) 
in the South of the country. (3.3%) were Foreigners. 
 
3.2.2 Knowledge, attitude and practices regarding HIV/AIDS  
About twenty percent of the respondents had previous blood transfusion or 
surgical intervention and the majority of them (79.8%) didn’t experience any of 
these procedures. (Fig.6). 
 More than seventy% of the TB patients heard about the syndrome AIDS, but 
(26.5%) of them never heard about it. (Fig. 7) 
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The relationship between Knowledge about AIDS and risky procedures like 
blood transfusion or surgical intervention is shown in (Table 1). Out of 61 
patients who had either blood transfusion or surgical operations, 43 of them had 
also heard about AIDS, while similar percentage (74.5%) of those who had not 
experienced such procedures, also heard about AIDS. There is no statistical 
significant difference between the two groups regarding hearing about AIIDS 
and going through blood transfusions or surgical operations.  
[Parts of tables 2,3,4,5 and 7 concerned with the knowledge about the male 
condom is interpreted in section 5.2.3] 
The association between the knowledge about AIDS and gender is shown in 
(Table 2). 
Hundred and fifty one males (78.2%) and seventy one females (65.1%) said that 
they had heard about AIDS. The difference between the males and females 
regarding hearing about AIDS was found to be statistically significant (p<0.01). 
Table 3 revealed that (76.9%) of the respondents within the Age group(16-
21yrs), had heard about AIDS,  and so are (92.9%) of the (22-27yrs)  group, 
(77.6%) of the (28-33yrs) group, (71%) of the (34-39yrs)group, (68.3%) of the 
(40-45yrs) group,(58.3%) of the (46-51yrs) and (44.1%) of the (52-60yrs) 
groups. 
The difference within the Age groups is also statistically significant (p<0.001). 
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When respondents of different occupations had been asked about AIDS, (95.2 
%) of the students answered positively, and so did (100%) of the teachers, (76.1 
%) of the laborers, (100%) of the civil servants, (84.1%) of those who are self 
employed, (37.5%) of the farmers, (100%) of the military personnel, (64 %) of 
housewives, (100%) of the retired and (63.3 %) of those who are unemployed. 
The difference among the groups was found to be statistically significant 
(p<0.01), (Table 4). 
Table 5 is showing the relationship between the respondents’ marital status and 
their knowledge about AIDS. About seventy percent of the married ones said 
that they had heard about AIDS and so did (77.8%) of the divorced, (26.7%) of 
the widowed and (89.6%) of those who had never been married. The difference 
between the four groups was statistically significant. (p<0.001). 
Table 6 shows that (68.4%) of those who had married more than once, had 
heard about AIDS, and so are (63.3%) of those who had one husband or wife, 
and (89.6%) of those who had never married before. The difference between the 
three groups was found to be statistically significant (p<0.001). 
Table 7 exhibits significant statistical difference in the knowledge about AIDS 
by the respondents when they were categorized according to their different 
education levels (p<0.001). Seventy two percent of those who went to the 
Khalwa claimed that they had heard about AIDS, and so were the responses of 
all patients who had Pre-school education, (87.7%) of those who had Basic 
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education, all of the patients who had Intermediate level of education, 96.2% of 
those who had Secondary education and all of those who attained the University 
Level or who are Post Graduates. 
Less than half of the Illiterates (48.4%) said that they had heard about AIDS.  
At mass media level: (16.6%) of the patients mentioned the radio as the source 
of information about AIDS, the television for (4.6%), the news papers for (1%). 
(4%) said the health workers, (13.6%) had their knowledge from their relatives 
and friends and (33.7%) mentioned more than one source.  
(Fig. 8) 
Figure 9 shows that only 2% of the patients recognized fever as a symptom of 
AIDS, and even less than that, a (1.7%) mentioned diarrhea. About eleven 
percent mentioned weight loss, but 8.6% mentioned more than one symptom. 
Few patients (2.6%) recalled other, non- significant symptoms. Almost half of 
the patients (47.7%) did not recognize a single symptom.   
More than half of the patients (54%) did not identify the germ which causes the 
HIV infection and only (19.5%) mentioned virus as a cause of infection. (Fig. 
10). 
Almost one third of the respondents think that the HIV infected person can look 
healthy, while (28.4%) do not think so, and (41%) don’t know. (Fig. 11) 
Regarding the knowledge about modes of transmission of HIV ,(15.6%) 
recalled sexual transmission, (2.6%) only mentioned blood transfusion, and 
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even less (0.3%) mentioned mother to child transmission, (2%) recognized skin 
penetration, (32%) cited more than two methods and (20.2%) did not know any 
mode of transmission. (Fig. 12) 
Figure 13 shows the distribution of the patients according to their knowledge 
about HIV prevention methods. Seven percent mentioned sticking by a single 
uninfected faithful partner, (13.6%) and (3.6%) said by avoiding extramarital 
sex and skin penetration respectively. Only (1.6%) mentioned the use of 
condom. (26.5%) recalled more than method and (21.2%) don’t know any 
prevention method. 
The TB patients believed in certain concepts about HIV transmission. About 
one fifth referred to the mosquitoes’ bite, 10.9% think that eating with an AIDS 
patient can transmit the infection and 54% mentioned the reuse of disposable 
syringes. (Fig. 14) 
Regarding HIV infection transmission from the mother to her unborn 
child,(57.6%) didn’t know any method, (32.1%) said through the 
placenta,(1.3%) only said during labor, (3.6%) mentioned by breast feeding and 
(5.4%) mentioned irrelevant methods. (Fig. 15)  
Certain stigmas and misconceptions are connected with AIDS .(33.8%)of the 
respondents think that they can get HIV infection by nursing  AIDS patients and 
(41.7%) of them think so by just eating with them.(43.2%) said that they would 
forbid AIDS students go to school and (42.7%) think that teachers who have 
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AIDS should not continue teaching. More than half of the patients (56.3%) said 
that they would not buy from an AIDS food seller and (21.5%) would hide a 
relative who has AIDS disease. (Fig.16).  
Figure 17 reveals that out of those who recognized AIDS only (9.3%) had been 
previously tested for HIV and (64.2%) didn’t run such a test. Of those who had 
the test, (1.7%) had done it voluntarily and (7.6%) had been asked to do it. (Fig 
18) 
When the respondents had been questioned about hazardous practices which 
can lead to HIV infection, 7.9% said that they had reused a disposable syringe, 
9.9% referred to the boiling of disposable syringes in the health facilities they 
attend and 20.9% admitted that they use a razor which have been used by 
someone else. (Fig. 19) 
As is indicated in (Table 8) the education level had no significant effect 
regarding the reuse of disposable syringes and razors.  
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3.2.3 Knowledge and Use of Male Condom 
About one tenth of the respondents heard about the condom, similarly (10.9%) 
heard and saw it but the majority (78.5%) never saw or heard about it. (Fig. 20) 
Regarding the knowledge about condom, there is a high significant difference 
between males and females (p<0.001), as in (Table 2), between the age groups 
(p<0.01) in (Table 3), among different occupations (p<0.01) in (Table 4), with 
reference to their marital status (p<0.001) in (Table 5) and their education level 
(p<0.001) as in (Table 7) 
Figure 21 presents the sources of knowledge about the condom where (1.7%) 
of respondents mentioned the Radio, (1.3%) referred to the TV, (2%) said from 
relatives, (0.7%) from news papers, (2.6%) from health units, (1.7%) from 
pharmacies, (7.6%) from friends and (3.9%) mentioned other sources. 
Among those who knew about the condom (3.6%) claimed that they had used it 
before and (17.9%) said that they had never used it. (Fig. 22) 
There is a statistically significant difference between males and females 
(p<0.001) and among different education levels (P<0.01) regarding the use of 
condoms (Tables 9&10) respectively. 
Of those (3.6%), (0.7%) used it to prevent HIV infection, (1.6%) to prevent 
STIs and (1.3%) used it as means of contraception. (Fig 23) 
The previous and current sex practices for the married and un-married patients 
are presented in (Fig. 24).Almost eighty one percent  never had any sexual 
 72
relations, (7%)of them have sex, (10.3%) had it in the past and (2%)had been 
sexually active before marriage.  
For married and non married respondents, their knowledge about AIDS in 
relation to their Sex practices is exhibited in (Table 11). There is a statistically 
significant difference between the two groups (p<0.001). 
On the other hand there is no statistical significant difference in the sex 
practices of the respondents with regard to their marital status. (Table 12)  
Median age for practicing sex for the first time is 19 years. The median number 
of sex partners was 3 and the mode was 1 partner. 
There was no reference to homosexual relations. Eighteen percent of the 
sexually active patients were males and have sex with females only and (1%) 
were females and have sex with males only. (Fig. 25) 
Motives for practicing sex outside marital boundaries included economic 
reasons (0.3%), for pleasure (15.6%), to imitate peers (2.3%), and to spend time 
(1%). (Fig. 26)  
About five percent of the respondents confessed that their sex partners practice 
sex on commercial basis, (7.9%) said they were not and (6%) don’t know. (Fig. 
27)  
Few of the patients (1.7%) used condom for last sex, negligible percent (0.3%) 
had used it regularly, (1%) only had used it infrequently during the last year and 
(16.2%) had never used it. (Fig. 28) 
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3.2.4 Sexually Transmitted Infections 
More than three quarters (83.7%) of the patients did not complain of any 
genito-urinary symptoms. Twelve percent of them complained of genital 
discharge, (3%) complained of itching and (1%) said that they have genital 
ulcer. (Fig. 29) 
In presence of these symptoms (2%) of the respondents do not use medical 
treatment, (4.3%) practice sex and (13.5%) do not use the condom. (Fig.30). 
The education level of the respondents had no significant effect on their 
practices when they have those symptoms. (Table 13). 
Eleven percent said that they would head for the health unit if they had 
symptoms, (4.3%) would go to a private clinic, (0.3%) would contact a 
pharmacy and (0.6%) would tell friends or relatives. (Fig. 31) 
 
3.2.5 Information, Education and Communication 
About one third (35.1%) of the patients have Radio only, 4.3% have TV only, 
41.4% have both Radio and TV but 19.2% have neither Radio nor TV. 
 (Fig 32) 
Sixteen percent think that the radio is the best mean for telling people about 
AIDS, while 4.6% think the TV is the best, 4% mentioned religion personnel, 
3.3% said public talks, 0.3% suggested the mobile Cinema. Schools, friends and 
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leaflets were suggested by 1.3%, 2%, 1.7% respectively, 35.4% mentioned 
more than one media and 31.5% don’t know. (Fig. 33) 
Only 20.2% received educational materials about AIDS and the rest did not 
receive any materials. (Fig. 34) 
3.2.6. TB Disease 
Figure35 Shows the duration of the TB disease. More than two thirds of the 
patients  (68.9%) had the disease for a year or less,11.6% of them had it  for 
two years, 4%of them, 4% of them  and 2.6% of them   had the disease for 3,4 
and 5 years respectively. 
About nine percent had it for more than 5 years. 
The majority of the patients (76.5%) were on treatment but still (23.5%) of 
them were without treatment (Fig. 36) 
 About two third of the patients (65.6%) had treatment before but 34.4% did not 
receive any treatment. (Fig 37). 
Those who had treatment before mentioned different reasons for stopping it. 
Two percent said the drugs were not available, (4%) said no money, (5.6%) 
referred to the long duration of treatment and (6.6%) mentioned other reasons. 
(Fig 38)  
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Figure(1)The distribution of the TB patients according to their 
occupation (n=302) 
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Figure(2)The distribution of the TB patients regarding 
their marital status (n=302)
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Figure (3) The distribution of TB patients who had more 
than  one husband/wife (n=302)
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Figure(4) The distribution of TB patients regarding their 
education level (n=302)
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Figure (5)The Distribution of patients according to the place 
of birth (n=302)
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Figure (6) The distribution of the TB patients who had 
previous blood transfusion or surgical intervention 
(n=302)
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Figure (7) The distribution of TB Patients who have heard 
about HIV/AIDS   (n=302)
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Figure(8)Sources of knowledge about HIV/AIDS
 (n=302)
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Figure (9)The distribution of TB patients regarding their 
knowledge about AIDS  symptoms(n=302)
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Figure(10) The distribution of patients who know the type of 
Germ that causes HIV infection (n=302)
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Figure (11)The distribution of TB patients who think 
that the HIV infected person can look healthy (n=302)
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Figure (12)The distribution of TB patients regarding their 
knowledge about modes of transmission of HIV infection 
(n=302)  
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Figure(13)The distribution of TB patients according to their 
knowledge about HIV prevention methods(n=(302)
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Figure(14)Concepts about HIV transmission(n=302)
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Figure (15) The distribution of TB  patients according to 
their knowledge about methods of HIV/AIDS 
transmission from mother to child (n=302)
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Figure(16)Stigma and misconceptions regarding people living 
with HIV/AIDS(n=302)
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Figure(17) The distribution of TB patients who had 
previous HIV blood testing (n=302)
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Figure(18) Reasons for HIV testing (n=302)
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Figure (19) Hazardous practices for HIV 
transmission(n=302)
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Figure ( 20) The distribution of TB patients according to 
their knowledge about the male condom (n=302)
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Figure(21)Sources of knowledge about male condom(n=302)
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Figure(22) Use of male condom among TB patients 
(n=302)
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Figure (23) Reasons for condom use (n=302)
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Figure(24) Previous and current sex practices for 
married and unmarried patients (n=302)  
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Figure (25) The distribution of Sex Partners by gender   (n=58)
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Figure(26) Motives for practicing sex outside marital 
boundaries (n=302)
0.30%
15.6%
2.3%1.00%
80.80%
Economic
Pleasure
Imitate peers
Spend time
NAP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 101
5.30% 6%
7.90%
80.80%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
YES Don't know NO NAP
PARTNERS
Figure(27)The distribution of sex partners who practice sex 
on commercial basis(n=302)
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Figure(28)The distribution of patients who used condom 
during the last year (n=302) 
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Figure(29) The distribution of TB patients who have genito-
urinary symptoms (n=302)
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Figure(30) Practices of patients when they have genito-
urinary problems
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Figure(31) Respondants' actions when they face genito-
urinary problems (n=302)
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Figure (32)The Percentage of the respondents who 
possess  Radio/TV (n=302)
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Figure (32)The Percentage of the respondents who 
possess  Radio/TV (n=302)
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Figure (34)The distribution of patients who received any 
educational materials about AIDS  (n=302)
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Figure (35)The distribution of the TB patients according 
to the duration of their disease(n=302)
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Figure (36) The distribution of TB patients who are on 
treatment (n=302)
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Figure (37) The Percentage of patients who had TB 
treatment before (n=302)
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Figure(38) Reasons for stopping TB treatment (n=302)
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Table (1) Knowledge about AIDS in relation to the 
respondents’ history of blood transfusion 
or surgical intervention (n=302) 
 
 
 
                                                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blood Transfusion / 
Surgical intervention 
Total Heard about AIDS 
 
Yes 61 
100.0% 
43 
70.5% 
No 239 
100.0% 
178 
74.5% 
I don't  know 2 
100.0% 
1 
50.0% 
Total 302 
100.0% 
222 
73.5% 
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Table (2) Knowledge about AIDS and male condom / the 
respondents’ gender (n=302) 
 
Ever heard about/seen a condom 
 
 
 
Gender 
 
 
Total 
 
Heard about 
AIDS 
n (%) 
Didn’t 
hear/see 
Heard about 
condom 
Heard/saw 
condom 
Male 193 
100.% 
151 
78.2% 
136 
70.5% 
25 
13.0% 
32 
16.6% 
Female 109 
100.0% 
71 
65.1% 
101 
92.7% 
7 
6.4% 
1 
0.9% 
Total 302 
100.0 
222 
73.5% 
237 
78.5% 
32 
10.6% 
33 
10.9% 
 
                             P= <0.01                                     P= <0.001 
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           Table (3) Knowledge about AIDS and male condom / the 
                                             age group (n=302) 
 
Ever heard about/seen a condom 
 
 
Age 
Group 
 
Total 
 
Heard about 
AIDS 
N (%) 
Didn’t 
hear/see 
Heard about 
condom 
Heard/saw 
Condom 
16 – 21 39 
100.0% 
30 
76.9% 
33 
84.6% 
4 
10.3% 
2 
5.1% 
22 – 27 70 
100% 
65 
92.9% 
47 
67.1% 
9 
12.9% 
14 
20.0% 
28 – 33 58 
100% 
45 
77.6% 
45 
77.6% 
8 
13.8% 
5 
8.6% 
34 – 39 31 
100% 
22 
71.0% 
25 
80.6% 
3 
9.7% 
3 
9.7% 
40 – 45 41 
100% 
28 
68.3% 
32 
78.0% 
5 
12.2% 
4 
9.8% 
46 – 51 29 
100% 
17 
58.3% 
25 
86.2% 
2 
6.9% 
2 
6.9% 
52 – 60 34 
100% 
15 
44.1% 
30 
88.2% 
1 
2.9% 
3 
8.8% 
Total 302 
100% 
222 
73.5% 
237 
78.5% 
32 
10.6% 
33 
10.9% 
 
                                                P = <0.001                             P =< 0.01 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 116
                Table (4) Knowledge about AIDS and male condom / the 
                                  respondents’ occupation (n=302)  
 
Ever heard about/seen a Condom 
 
 
Occupation  
 
Total 
Heard about 
AIDS 
n (%) Didn’t 
hear/see  
Heard about 
condom 
Heard/saw 
condom 
Student 21 
100.0% 
20 
95.2% 
14 
66.7% 
5 
23.8% 
2 
9.5% 
Teacher 6 
100.0% 
6 
100.0% 
3 
50.0% 
3 
50.0% 
0 
Laborer 46 
100.0% 
35 
76.1% 
33 
71.7% 
4 
8.7% 
9 
19.6% 
Civil Servant 9 
100.0% 
9 
100.0% 
5 
55.6% 
2 
22.2% 
2 
22.2% 
Self 
employed 
69 
100.0% 
58 
84.1% 
52 
75.4% 
9 
13.0% 
8 
11.6% 
Farmer 24 
100.0% 
9 
37.5% 
23 
95.8% 
0 1 
4.2% 
Military 
personnel 
7 
100.0% 
7 
100.0% 
3 
42.9% 
1 
14.3% 
3 
42.9% 
Housewife 25 
100.0% 
16 
64.0% 
22 
88.0% 
2 
8.0% 
1 
4.0% 
Retired 5 
100.0% 
5 
100.0% 
3 
60.0% 
1 
14.3% 
3 
42.9% 
Unemployed 90 
100.0% 
57 
63.3% 
79 
87.8% 
6 
6.7% 
5 
5.6% 
Total 203 
100.0% 
222 
73.5% 
237 
78.7% 
32 
10.6% 
33 
10.9% 
                                                            P =< 0.01                            P = <0.01 
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Table (5) Knowledge about AIDS and male condom / the 
respondents’ marital status (n=302) 
 
Ever heard about / seen a condom 
 
 
Marital 
status 
 
Total 
 
Heard about 
AIDS 
n (%) 
Didn’t 
hear /see 
Heard about 
condom 
Heard /saw 
condom 
Married 163 
100.0% 
109 
66.9% 
133 
81.6% 
16 
9.8% 
14 
8.6% 
Divorced 18 
100.0% 
14 
77.8% 
17 
94.4% 
1 
5.6% 
0 
Widow 15 
100.0% 
4 
26.7% 
15 
100.0% 
0 0 
Never 
Married  
before 
106 
100.0% 
95 
89.6% 
72 
67.9% 
15 
14.2% 
19 
17.9% 
Total 302 
100.0% 
222 
73.5% 
237 
78.5% 
32 
10.6% 
33 
10.9% 
             P = < 0.001                                 P=<0.001 
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Table (6) Knowledge about AIDS / the respondents’ 
     who have more than one husband / wife (n=302) 
 
 
Male/Female 
 
Total 
 
Heard about AIDS 
n (%) 
Yes 57 
100.% 
39 
68.4% 
No 139 
100.0% 
88 
63.3% 
Nap 106 
100.0% 
95 
89.6% 
Total 302 
100.0% 
222 
73.5% 
 
                                                                                P =< 0.001 
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Table (7) Knowledge about AIDS and male condom in relation 
to the respondents’ education (n=302) 
  
 
Ever heard about/seen a condom 
 
Education    
 
Total 
 
Heard about 
AIDS 
       n (%) 
Didn’t 
Hear/see  
Heard about 
condom 
Heard/saw 
condom 
Khalwa 25 
100.0% 
18 
72.0% 
19 
76.0% 
3 
12.0% 
3 
12.0% 
Pre - School 2 
100.0% 
2 
100.0% 
2 
100.0% 
0 0 
Basic 57 
100.0% 
50 
87.7% 
44 
77.2% 
8 
14.0% 
5 
8.8% 
Intermediate  16 
100.0% 
16 
100.0% 
11 
68.8% 
1 
6.3% 
4 
25.0% 
Secondary 52 
100.0% 
50 
96.2% 
30 
57.7% 
7 
13.5% 
15 
28.0% 
University 25 
100.0% 
25 
100.0% 
10 
40.0% 
10 
40.0% 
5 
20.0% 
Post 
Graduate  
1 
100.0% 
1 
100.0% 
0 1 
100.0% 
0 
Illiterate 124 
100.0% 
60 
48.4% 
121 
97.6% 
2 
1.6% 
1 
0.8% 
Total 302 
100.0% 
222 
73.5% 
237 
78.5% 
32 
10.6% 
33 
10.9% 
                                                             P =<0.001                               P = <0.001 
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Table (8) Reuse of disposal syringes & razors / 
education level (n=302) 
 
Education Level Total Disposal syringes Razors 
Khalwa 25 
100.0% 
1 
4.0% 
8 
32.0% 
 
Pre-School 2 
100.0% 
0  0 
Basic 57 
100.0% 
2 
3.5% 
11 
19.3% 
Intermediate  16 
100.0% 
2 
12.5% 
2 
12.5% 
Secondary 52 
100.0% 
0  
 
13 
25.0% 
University 25 
100.0% 
14 
11.3% 
3 
12.0% 
Post Graduate  1 
100.0% 
0 0  
  
Illiterate 124 
100.0% 
14 
11.3% 
26 
21.0% 
Total 302 
100.0% 
24 
7.9% 
63 
20.9% 
                                                                                      .                 
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Table (9) Use of male condom / gender 
(n=302) 
 
Gender 
 
Total Use of  Condom 
Male 
 
193 
100% 
 
10 
5.2% 
Female 
 
109 
100% 
 
1 
0.9% 
Total 
 
302 
100% 
 
11 
3.6% 
 
                                                              P=<0.001 
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Table (10) Use of male condom according to the 
       education level    (n=302) 
 
Education Level Total Condom use 
Khalwa 25 
100% 
0 
Pre-School 2 
100% 
0 
Basic 57 
100% 
1 
1.8% 
Intermediate 16 
100% 
2 
12.5% 
Secondary 52 
100% 
5 
9.6% 
University 25 
100% 
3 
12.0% 
Post Graduate 1 
100% 
0 
Nap 124 
100% 
0 
Total 302 
100% 
11 
3.6% 
 
                                                                                                                  P=<0.001 
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Table (11) Knowledge about AIDS / sex practice 
(now and before) for married (M) and not 
married   (NM) respondents (n=302) 
 
 
                                                                                                        P =< 0.001 
 
 
                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Sex     practice  
  now/ before  
Total Heard about AIDS 
                 n (%) 
Never (NM) 244 
100.0% 
169 
69.3% 
Yes now (M/NM) 
 
21 
100.0% 
20 
95.2% 
Yes but in the past 
(M/NM) 
31 
100.0% 
27 
87.1% 
Yes but before marriage  6 
100.0% 
6 
100.0% 
Total 302 
100.0% 
222 
73.5% 
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Table (12) Sex practices outside marital boundaries / 
respondents’ marital status (n=302) 
 
  
Sex  practices 
  
before 
marriage  
in the past now  Never  
Total 
n (%) 
Marital Status  
6 
3.7%  
17 
10.4% 
6 
3.7%  
134 
82.2%  
163 
100.0%  
Married  
0 
  
1 
5.6% 
1 
5.6%  
16 
88.9%  
18 
100.0%  
Divorced  
0  1 
6.7% 
0  14 
93.3%  
15 
100.0%  
Widow 
0 
  
12 
11.3% 
14 
13.2%  
80 
75.5%  
106 
100.0%  
Single 
6 
100.0%  
31 
10.3%  
 
21 
7.0%  
244 
80.8%  
302  
100.0%  
Total  
 
                                                                                                                . 
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Table (13) Use of treatment (now/before) for genito-urinary symptoms, Sex 
practice and condom use in presence of symptoms/respondents’ education 
Level (n=302) 
                                                                  
 
                              
                                
Education 
Level 
Total Use  Med. 
Treatment 
 
Practice  sex 
in presence of 
symptoms 
 
Have 
symptom 
now 
&asked 
/used 
condom 
Have 
symptom 
now & 
didn't ask/ 
use 
condom 
Had 
symptoms 
asked/used 
condom 
 
Had 
symptoms 
&didn't ask 
/use 
condom 
Khalwa 25 
100.0% 
1 
4.0% 
1 
4.0% 
 
0 0 0 2 
8.0% 
Pre-School 2 
100.0% 
1 
50.0% 
0 0 0 0 0 
Basic 57 
100.0% 
12 
21.1% 
2 
3.5% 
0 2 
3.5% 
0 10 
17.5% 
Inter- 
mediate 
16 
100.0% 
2 
12.5% 
1 
3.5% 
0 1 
6.3% 
0 1 
6.3% 
Secondary 52 
100.0% 
9 
17.3% 
1 
6.3% 
0 2 
3.8% 
2 
3.8% 
4 
7.7% 
University 25 
100.0% 
4 
16.0% 
1 
1.9% 
0 0 0 5 
20.0% 
Post- 
Graduate 
1 
100.0% 
0 2 
8.0% 
0 0 0 0 
NAP 124 
100.0% 
14 
11.3% 
6 
4.8% 
1 
8.0% 
3 
2.4% 
0 11 
8.9% 
Total 302 
100.0% 
43 
14.2% 
13 
4.3% 
1 
3.0% 
8 
2.6% 
2 
7.0% 
33 
10.9% 
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DISCUSSION 
 
The rising prevalence of HIV/AIDS has a world-wide impact on 
development with high morbidity, mortality rates and deterioration in the 
socio-economic status of the affected people.  
Since the HIV epidemic has increased the global tuberculosis burden, it also 
increased attention on the need to strengthen links between TB and 
HIV/AIDS programmes  in  order  to  tackle  these  public  health  
emergencies  more 
 effectively. (44) 
Globally, many of the people infected with HIV do not know that they are 
carrying the virus, nor do they know much about the disease. Knowledge 
about the disease and the risky behaviors leading to it could have helped 
them avoid acquiring the virus .It is a vital step towards halting the epidemic 
and overcoming the prejudice and fear faced by people living with 
HIV/AIDS.(27) 
The findings of this study were based on a survey, consisting of 
epidemiological and behavioral components conducted on 302 tuberculosis 
patients for each component. 
The overall HIV sero-prevalence among TB patients was found to be high 
and in sharp contrast to the prevalence reported in the national survey 
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carried out by SNAP in 2002, and to the prevalence in the Final Report 
(Dec.2004) of the HIV/AIDS Control Programme, Khartoum State, (46, 47) 
however it is similar to the range of prevalence estimated by the UNAIDS 
for the same period (37),  
but is still less than that reported from Nigeria, Mozambique, Chad and  
Thailand. (59, 60, 61, 62) 
Such high prevalence was expected as TB is considered to be the most 
common opportunistic infection in PLWH. 
 HIV epidemics in any country are complex; the demand for the behavioral 
data is increasing as different populations are tied by complex behaviors. (35) 
Almost half of the patients under study were originally from the western part 
of the country. For the past two decades these regions has been wrecked by 
drought and civil conflicts which had lead to mass population movement. 
Low awareness about HIV/AIDS, weakness in the health education and 
absence of tailored messages is reflected by the one quarter of patients who 
never heard about AIDS although the situation is better than at the time of 
the national survey in 2002 were 40% of the patients were not aware of the 
disease (47). 
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 Here comes the role of the HIV/TB control ptogrammes at the Federal and 
State level regarding enlightening the people about the disease and the risky 
behaviors which can lead to it. 
Mass media had always an undeniable role in conveying health education 
messages. In this study the Radio was cited as the main source of 
information about HIV/AIDS as listening to the radio is part of the Sudanese 
daily rituals especially in areas where there is no television. 
News papers came on the tail of the list because of the illiteracy of almost 
half of the patients. 
Health workers are still not well trained to deliver useful information about 
the disease and this agrees with the responses of the patients surveyed in 
2002. (47) 
This is reflected on the poor knowledge about the symptoms and signs of 
AIDS, modes of transmission, prevention methods and the causative germ, 
where still people think that the mosquito’s bite can cause AIDS. Such 
believe is common due to the high prevalence of malaria in Sudan and the 
mosquitoes are connected with many illnesses. So the situation regarding 
information about the AIDS disease is by no means better than in 2002. (47) 
To respond promptly and effectively to the HIV/AIDS pandemic, complete 
and reliable information is needed about the attitudes, believes and practices 
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of communities at risk particularly about the sexual behaviors that can 
spread HIV. 
Monitoring changes in these behaviors and attitudes over time is essential 
for evaluating appropriately designed programmes. (33) 
HIV related stigma and discrimination remains an enormous barrier for 
effective fighting of the HIV/AIDS epidemic. Fear of discrimination often 
prevents people from getting tested, seeking treatment for AIDS or from 
admitting their HIV status publicly. (27) 
Against these backgrounds were the responses in many countries which had 
enacted legislations to protect the rights and freedom of people living with 
HIV and AIDS and to safeguard them from discrimination and to ensure 
their right to employment, education, privacy and confidentiality ,as well as 
the right to access  information, treatment  and support.(27, 28) 
The fact that a very low percentage of patients had been previously tested for 
HIV reveals that while HIV and TB work together in a deadly partnership, 
they are still addressed as two separate epidemics by two separate, less 
effective programmes. 
There were more patients tested than in the last National survey (1.5% in 
2002) because many employers are now asking for pre-employment 
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screening and HIV free certificates although this is considered within the 
context of stigma and discrimination. 
The low number of ever or current condom use is related to the total 
ignorance of the public about the condom existence in the first place. As it is 
clear condom use has never been part of the Sudanese culture not even as 
mean of contraception or as a mean of protection against other STIs as it is 
still considered as a taboo. The issue of condom use is still a point of 
controversy as Sudan is considered to be a Muslim, conservative country but 
at the same time with a vast ethnic and cultural diversity which has to be 
taken into consideration. Acceptance and use of condoms especially for 
married couples with STIs is obviously related to the concept of trust in the 
partner and need improvement  as there  is no  much  change  about  this  
matter  since  the  last 
survey. (47) 
The results of the study indicate that sexual practices continue to involve 
high risks. The median age for practicing sex for the first time is one year 
less than 
 in  the  last survey  but  higher than  the  in  the study  carried out  in Chad             
(16.3 years).  (47, 61)                                         
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The median number  of sex partners is high considering the fact that most 
people practice unprotected sex and a significant number do not know if 
their sex partners practice sex on commercial basis or not. 
There was no referral to any homosexual relations and this is either related 
to the conservative nature of the community or they do not exist in contrast 
to the study carried out in Jakarta. (66)  
The reported episodes of STIs symptoms conform to the results of the last 
survey. (47) 
The self-reported STIs incidences need to be accompanied by laboratory 
tests since each new infection not only increases HIV transmission, but also 
carries the potential of other serious complications. (30, 33) 
The slight increase in the percentage of patients who received education 
material about AIDS  compared to the percentage in 2002 (from 16% to 
20.2%)7, emphasizes the urgency for extensive education campaigns 
mobilized by leaders at all levels and in all sectors and customized for 
different audiences who have different frames of references.(26) 
The catalytic link between HIV and TB means that we can expect several 
million additional new TB in the years ahead if HIV is to continue its 
unchecked spread. (44) 
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The high number of the study population who had the disease in the past 
year mirrors the deteriorating health and socio-economic conditions. 
Health care seeking and compliance with TB treatment is the key to the 
control of the disease. The high percentage of patients who had treatment 
before, demonstrates either a substantial level of drug resistance or non 
compliance with treatment for different reasons. 
Efforts should be intensified to ensure adherence to the DOTs and provision 
of TB prophylaxis for PLWH.  
As the patients were not offered counseling, they were not asked if they 
know about the relationship between HIV infection and TB and this was one 
of the limitations of the study.    
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CONCLUSION 
 
 
• The overall HIV sero-prevalence among tuberculosis patients was 
7.6%. 
 
• About three –quarters of the TB patients recognized the disease AIDS, 
but there is no much change in knowledge and practices of the TB 
patients regarding HIV/AIDS modes of transmission, hazardous 
practices or in their attitudes towards PLWH since the last National 
survey carried out by SNAP in 2002. 
 
• Education has significant effect on the perception of AIDS and male 
condom by the patients but has no effect considering the hazardous 
practices and the patients’ practices in presence of STIs symptoms. 
 
• Age, gender and occupations were significantly correlated to the 
knowledge about AIDS and male condom. 
 
• Information and Education about AIDS are still weak and are not at 
reach for everyone especially young people. 
 
•  Mass population movements due to civil conflicts in different parts of 
the country and deterioration in socio-economic conditions could have 
lead to the increase in the prevalence of both HIV infection and TB 
disease in the past years.  
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• HIV/AIDS constitute a social phenomena as well as a medical 
concern. PLWH are highly stigmatized and discriminated and 
sometimes demonized and feared.  
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RECOMMENDATIONS 
 
 
 
• HIV and TB control programmes need each other so they must 
collaborate to reduce transmission of both infections and to 
improve care and support for their respective patients.    
• TB  patients’ access to voluntary HIV counseling and testing 
(VCT) can be improved by introducing such services into TB 
clinics or by building strong referral mechanisms between these 
clinics and existing HIV voluntary counseling and testing services. 
In both cases healthcare workers have to be trained to educate TB 
patients about HIV and inform the patients about the availability of 
such services.  
• Provision of ART and anti-tuberculosis preventive therapy as INH 
for all HIV/AIDS patients in addition to follow up counseling, 
protection from stigma and discrimination, treatment of STIs, and 
the prevention and treatment of other opportunistic infections and 
palliative therapies. 
• Socioeconomic support as PLWH and their families are confronted 
with additional challenges throughout the course of infection in the 
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form of isolation, loss of income, medical and transport expenses 
beside other necessities. 
• Health education is the cornerstone for the control of HIV. 
Education about the disease, its nature and routes of transmission, 
methods of prevention, stigma and wrong believes, must occur 
through all avenues (formal and non-formal), through schools and 
through broader community channels with strong political support. 
It should also match the various linguistic, social and cultural 
differences existing in the country and customized for different 
audiences. 
• Strict blood surveillance and blood safety programmes are highly 
recommended. These include mandatory screening of blood and 
blood products and donors for organ transplants. 
•    Sustained periodic or sentinel surveys and behavioral data 
surveys for HIV among different population sectors are 
recommended to supplement the results of routine testing and to 
reveal the local dynamics of the epidemic and to identify the local 
attitudes and needs to tailor preventive messages effectively. 
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   ﺷﻌﺒﺔ ﻃﺐ اﻟﻤﺠﺘﻤﻊ- ﻣﺠﻠﺲ اﻟﺪراﺳﺎت اﻟﻄﺒﻴﺔ اﻟﻌﻠﻴﺎ–ﺟﺎﻣﻌﺔ اﻟﺨﺮﻃﻮم 
   وزارة اﻟﺼﺤﺔ اﻻﺗﺤﺎدﻳﺔ–ﺑﺎﻟﺘﻌﺎون ﻣﻊ اﻟﺒﺮﻧﺎﻣﺞ اﻟﻘﻮﻣﻲ ﻟﻤﻜﺎﻓﺤﺔ اﻻﻳﺪز 
  4002 – ﻭﻻﻳﺔ ﺍﻟﺨﺮﻃﻮﻡ –ﺩﺭﺍﺳﺔ ﺳﻠﻮﻛﻴﺔ ﻭﻣﺼﻠﻴﺔ ﻋﻦ ﻋﺪﻭﻱ ﻓﻴﺮﻭﺱ ﻋﻮﺯ ﺍﻟﻤﻨﺎﻋﺔ ﺍﻟﺒﺸﺮﻱ ﺑﻴﻦ ﻣﺮﺿﻲ ﺍﻟﺪﺭﻥ 
 
  :ﻣﻌﻠﻮﻣﺔ ﺗﻌﺮﻳﻔﻴﺔ ﻟﻠﻤﺒﺤﻮث
ﻳﻘﻮم اﻟﺒﺮﻧﺎﻣﺞ ﺑﺪراﺳﺔ ﺑﻴﻦ ﻣﺮﺿﻲ اﻟﺪرن ﺑﺎﻟﺨﺮﻃﻮم ﻋﻦ اﻟﻤﻌﺮﻓﺔ و اﻻﺗﺠﺎهﺎت و اﻟﺴﻠﻮك و ﻣﻌﺮﻓﺔ . اﻋﻤﻞ ﻣﻊ ﺑﺮﻧﺎﻣﺞ ﻣﻜﺎﻓﺤﺔ اﻻﻳﺪز...( ). أﻧﺎ اﺳﻤﻲ 
ﻟﻦ اﺳﺄﻟﻚ ﻋﻦ اﺳﻤﻚ او ﻣﻜﺎن . ﻟﺪي ﺑﻌﺾ اﻻﺳﺌﻠﺔ اﻟﺸﺨﺼﻴﺔ ﻟﻚ. اﻻﺻﺎﺑﺔ ﺑﺎﻷﻣﺮاض اﻟﻤﻨﻘﻮﻟﺔ ﺟﻨﺴﻴﺎ و ﻋﺪوي ﻓﻴﺮوس ﻋﻮز اﻟﻤﻨﺎﻋﺔ اﻟﺒﺸﺮي و اﻻﻳﺪز
ي ﻣﻌﻠﻮﻣﺎت اﺧﺮي ﻳﻤﻜﻦ ان ﺗﺆدي ﻟﻠﺘﻌﺮف ﻋﻠﻴﻚ، و اﺟﺎﺑﺎﺗﻚ ﺳﺘﻜﻮن ﻓﻲ ﻣﻨﺘﻬﻲ اﻟﺴﺮﻳﺔ، آﻤﺎ أن ﻟﻚ ﻣﻄﻠﻖ اﻟﺤﺮﻳﺔ ﻓﻲ اﻻﻋﺘﺬار ﻋﻦ اﻻﺟﺎﺑﺔ ﺳﻜﻨﻚ او ا
آﻞ ﻣﺎ أرﺟﻮﻩ ﻣﻨﻚ اﻟﺘﻌﺎون ﻣﻌﻨﺎ ﻓﻲ اﻻﺟﺎﺑﺔ ﺑﺼﺮاﺣﺔ و ﺻﺪق ﻋﻠﻲ آﻞ اﻻﺳﺌﻠﺔ ﻷن ذﻟﻚ ﺳﻴﺴﺎﻋﺪ ﻓﻲ . ﻋﻠﻲ اﻷﺳﺌﻠﺔ اﻟﺘﻲ ﻻﺗﺮﻏﺐ ﻓﻲ اﻻﺟﺎﺑﺔ ﻋﻠﻴﻬﺎ
ﻲ ﻣﺪي ادراك هﺬﻩ اﻟﺸﺮﻳﺤﺔ  ﻟﺒﻌﺾ اﻟﺴﻠﻮآﻴﺎت اﻟﺘﻲ ﺗﺆدي ﻟﻼﺻﺎﺑﺔ ﺑﺄﻣﺮاض ﺧﻄﻴﺮة و ﻣﻬﺪدة ﻟﻠﺤﻴﺎة، آﻤﺎ ﻳﺴﺎﻋﺪ ﻓﻲ ﺗﺨﻄﻴﻂ اﻟﺒﺮاﻣﺞ اﻟﺼﺤﻴﺔ اﻟﺘﻌﺮف ﻋﻠ
  . دﻗﻴﻘﺔ06ﻳﺴﺘﻐﺮق اﻟﺒﺤﺚ ﺣﻮاﻟﻲ . اﻟﻤﻨﺎﺳﺒﺔ ﻟﻠﻮﻗﺎﻳﺔ ﻣﻦ هﺬﻩ اﻷﻣﺮاض
 
  :ﻣﻮاﻓﻘﺔ اﻟﻤﺒﺤﻮث
  . اﻟﻮاﻓﻲ، و أﻗﺮ ﺑﺬﻟﻚ ﺑﻤﻮاﻓﻘﺘﻲ ﻋﻠﻲ اﻟﻤﺸﺎرآﺔ ﻓﻲ هﺬا اﻟﺒﺤﺚ وهﺬا ﻣﻨﻲ ﻟﻼﻋﺘﻤﺎد أﺷﻬﺪ ﺑﺎﻧﻨﻲ ﻗﺪ ﻓﻬﻤﺖ اﻟﻘﺼﺪ ﻣﻦ اﺟﺮاء هﺬﻩ اﻟﺪراﺳﺔ ﺑﻌﺪ اﻟﺸﺮح
  
  :...................................... اﻟﺘﻮﻗﻴﻊ
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  ﻣﻌﻠﻮﻣﺎت دﻳﻤﻮﻏﺮاﻓﻴﺔ:  اﻟﻘﺴﻢ اﻷول  
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
       أﻧﺜﻲ-2ذآﺮ              .1  اﻟﻨﻮع  1
      اآﺘﺐ اﻟﻌﻤﺮ ﺑﺎﻟﺴﻨﻮات اﻟﻜﺎﻣﻠﺔ  (اﻟﺮﺟﺎء ﺗﻘﺪﻳﺮ اﻟﻌﻤﺮ ان ﻟﻢ ﻳﺴﺘﻄﻊ اﻟﻤﺒﺤﻮث ذﻟﻚ)اﻟﻌﻤﺮ  2
      اآﺘﺐ ﻧﻮع اﻟﻌﻤﻞ  ﺷﻐﺎﻟﺔ ﺷﻨﻮ؟/اﻧﺖ ﺷﻐﺎل  3
  هﻞ ﻋﻨﺪك اي ﻣﺼﺪر أو ﻣﺼﺎدر ﺗﺎﻧﻴﺔ ﻟﻠﺪﺧﻞ؟   4
  (اﻋﺎﻧﺎت ﻣﻦ اﻻهﻞ او اﻟﻤﻐﺘﺮﺑﻴﻦ/اﻳﺠﺎرات/ﻋﻘﺎرات)
  ﻧﻌﻢ       .1
  ﻻ .2
    
 ﻣﺘﺰوﺟﺔ   /ﻣﺘﺰوج .1  ﻣﺘﺰوﺟﺔ؟ /اﻧﺖ ﻣﺘﺰوج  5
 ﻣﻄﻠﻘﺔ            / ﻣﻄﻠﻖ .2
 أرﻣﻠﺔ            / أرﻣﻞ .3
  ﻣﻨﻔﺼﻠﺔ/ﻣﻨﻔﺼﻞ .4
    ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ اﻟﺰواج-99
اذا آﺎن اﻟﻤﺒﺤﻮث ﻏﻴﺮ   
ﻣﺘﺰوج اﻣﻸ ﺟﻤﻴﻊ اﻟﺨﺎﻧﻠﺖ 
 و اﻧﺘﻘﻞ ﻟﻠﺴﺆال 99ﺑﺎﻟﺮﻗﻢ 
  8رﻗﻢ 
أﻃﻔﺎﻟﻚ ﻋﺪدهﻢ : اﻧﺖ ﻋﻨﺪك أﻃﻔﺎل؟ اذا اﺟﺎب ﻧﻌﻢ اﺳﺄل  6
  آﻢ؟
  اآﺘﺐ ﺻﻔﺮ اذا اﻟﻤﺒﺤﻮث ﻣﺘﺰوج وﻟﻴﺲ ﻟﺪﻳﻪ اﻃﻔﺎل
  اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ اﻟﺰواج:  ﻻ ﻳﻨﻄﺒﻖ-99
    
اﻟﺰوﺟﺔ /هﻞ ﻟﺪﻳﻚ اآﺜﺮ ﻣﻦ زوﺟﺔ؟ او هﻞ ﺳﺒﻖ ﻟﻠﺰوج  7
  زوج ﻏﻴﺮ اﻟﺰوج اﻟﺤﺎﻟﻲ؟/اﻻرﺗﺒﺎط ﺑﺰوﺟﺔ
 ﻧﻌﻢ            .1
  ﻻ .2
  اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ اﻟﺰواج:   ﻻ ﻳﻨﻄﺒﻖ-99
    
 ﻧﻌﻢ                          .1  أ وﺗﻜﺘﺐ ؟ﺑﺘﻌﺮف ﺗﻘﺮ/ ﺑﺘﻌﺮﻓﻰ   8
  ﻻ .2
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  ﻗﺮﻳﺘﻰ ﻟﺤﺪى وﻳﻦ ؟/ ﻗﺮﻳﺖ   9
  
 ﺗﻌﻠﻴﻢ ﻗﺒﻞ اﻟﻤﺪرﺳﻰ       -2ﺧﻠﻮة               -1
   أوﺳﻂ-4أوﻟﻴﺔ   /  أﺳﺎس - 3   
  ﺟﺎﻣﻌﻰ-6  ﺛﺎﻧﻮى            -5   
 ﻓﻮق اﻟﺠﺎﻣﻌﻰ      -7
  (           ﻟﻢ ﻳﺘﻠﻖ اي ﺗﻌﻠﻴﻢ )  ﻻ ﻳﻨﻄﺒﻖ -9
    
  أﺻًﻼ اﺗﻮﻟﺪت وﻳﻦ ؟إﻧﺖ   01
  
   اﻟﻮﺳﻂ-2 اﻟﺨﺮﻃﻮم                 -1
   اﻟﺸﺮق-4 اﻟﻐﺮب                    -3
   اﻟﺠﻨﻮب -6 اﻟﺸﻤﺎل                    -5
    
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
آﻠﻤﺔ هﻨﺎ ﻳﻘﺼﺪ ﺑﻬﺎ ) ﻋﺎﻳﺸﺔ هﻨﺎ /ﻳﺶإﻧﺖ ﻟﻴﻚ آﻢ ﺳﻨﺔ ﻋﺎ  11
  (وﻻﻳﺔ اﻟﺨﺮﻃﻮم 
إن آﺎﻧﺖ . أآﺘﺐ ﻋﺪد اﻟﺴﻨﻮات ﻓﻰ اﻟﻌﻤﻮد اﻟﻤﻘﺎﺑﻞ
  (1)ﻣﺪة اﻟﻌﻤﻞ ﺳﻨﺔ أو أﻗﻞ ﻣﻦ ﺳﻨﺔ أآﺘﺐ 
    
  ﺣﺼﻞ ﻗﺒﻞ آﺪة ﻋﺸﺖ ﻓﻰ ﻣﻨﻄﻘﺔ ﻏﻴﺮ اﻟﻤﻨﻄﻘﺔ دى ؟  21
  (ﺗﻘﺺ ﻋﻦ اﻟﻤﻌﻴﺸﺔ ﺳﻨﺔ ﻋﻠﻰ اﻷﻗﻞ) 
 ﻧﻌﻢ                    .1
     ﻻ                      .2
إذا آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻼ إﻧﺘﻘﻞ   
 وأﻣﻼ ﺟﻤﻴﻊ 51ﻟﻠﺴﺆال رﻗﻢ 
  .99اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ 
  آﻢ ﻣﻨﻄﻘﺔ ﻋﺸﺖ ﻓﻴﻬﺎ ﺳﻨﺔ أو أآﺜﺮ ﻏﻴﺮ اﻟﻤﻨﻄﻘﺔ دى ؟  31
  
  أآﺘﺐ ﻋﺪد اﻟﻤﻨﺎﻃﻖ اﻟﺘىﻌﺎش ﻓﻴﻬﺎ ﺳﻨﺔ أو أآﺜﺮ
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﻌﺶ ﺧﺎرج وﻻﻳﺔ )  ﻻ ﻳﻨﻄﺒﻖ -99
اﻟﺨﺮﻃﻮم ﺑﺎﻟﻤﺮة أو ﻋﺎش ﻓﻰ ﺑﻌﺾ اﻟﻤﻨﺎﻃﻖ ﻟﻜﻦ 
  (ﻣﻦ ﺳﻨﺔ أﻗﻞ 
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ﻋﺎﻳﺸﺔ /ﺁﺧﺮ ﻣﻨﻄﻘﺔ ﻗﺒﻞ اﻟﻤﻨﻄﻘﺔ دى ﻣﺒﺎﺷﺮة  آﻨﺖ ﻋﺎﻳﺶ  41
  .ﻓﻴﻬﺎ وﻳﻦ ؟ ﺗﻘﺼﻰ ﻋﻦ اﻟﻤﻌﻴﺸﺔ ﺳﻨﺔ أو أآﺜﺮ 
  
 اﻟﺸﺮق -3 اﻟﻐﺮب       -2 اﻟﻮﺳﻂ   -1
   اﻟﺠﻨﻮب-5 اﻟﺸﻤﺎل       -4
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﻌﻤﻞ ﺧﺎرج وﻻﻳﺔ )  ﻻ ﻳﻨﻄﺒﻖ -99
 ﻟﻜﻦ اﻟﺨﺮﻃﻮم ﺑﺎﻟﻤﺮة أو ﻋﻤﻞ ﻓﻰ ﺑﻌﺾ اﻟﻤﻨﺎﻃﻖ
  (أﻗﻞ ﻣﻦ ﺳﻨﺔ 
    
  
  
  اﻟﻤﻌﺮﻓﺔ واﻟﺴﻠﻮك اﻟﻤﻬﺪد ﺑﺎﻻﺻﺎﺑﺔ ﺑﺎﻟﻌﺪوي : اﻟﻘﺴﻢ اﻟﺜﺎﻧﻲ  
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
  ﺣﺼﻞ ﻋﻤﻠﻮا ﻟﻴﻚ  ﻧﻘﻞ دم أو ﻋﻤﻠﻴﺔ ﺟﺮاﺣﻴﺔ ﻗﺒﻞ آﺪة ؟  51
  
 ﻻ  -2 ﻧﻌﻢ              -1
   ﻻ أذآﺮ ﻻ أﻋﺮف-3
    
إذا أﺟﺎب ﺑﻼ إﻧﺘﻘﻞ ﻟﻠﺴﺆال       ﻻ-2 ﻧﻌﻢ               -1  ﺣﺼﻞ ﺳﻤﻌﺖ ﻋﻦ اﻹﻳﺪز ؟  61
 وأﻣﻼ ﺟﻤﻴﻊ 73رﻗﻢ 
   9اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ 
  
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
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 ذآﺮ اﻧﻪ ﺳﻤﻊ ﺑﻤﺮض اﻻﻳﺪز ﻓﻰ اﻟﺴﺆال أﻋﻼﻩ اذا اﻟﻤﺒﺤﻮث 71
 ﺳﻤﻌﺖ ﻋﻨﻪ ﻣﻦ وﻳﻦ ؟:  أﺳﺄل 
  ﻻ ﺗﺬآﺮ إﺣﺘﻤﺎﻻت اﻹﺟﺎﺑﺔ
  .ﻳﻤﻜﻦ ان ﻳﺬآﺮ اﻟﻤﺒﺤﻮث اآﺜﺮ ﻣﻦ اﺟﺎﺑﺔ
 
 
 اﻟﺘﻠﻔﺰﻳﻮن  -2  اﻹذاﻋﺔ          -1
 اﻟﻌﺎﻣﻠﻮن ﺑﺎﻟﺼﺤﺔ-4 اﻟﺼﺤﻒ         -3 
 اﻻﺻﺪﻗﺎء اﻷهﻞ و اﻟﻤﻌﺎرف    -5
................... ﻏﻴﺮ ذﻟﻚ ﺣﺪد -6 
ﺗﺴﻤﻊ /اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻ ﻳﻨﻄﺒﻖ -9
   (ﺑﺎﻹﻳﺪز
  
ﻣﺮﻳﺾ  ﺗﻔﺘﻜﺮى ﺷﻨﻮ اﻷﻋﺮاض اﻟﻤﺮﺿﻴﺔ اﻟﺒﺘﻜﻮن ﻋﻨﺪ/ﺗﻔﺘﻜﺮ 81
  (ﻻ ﺗﺬآﺮ اﺣﺘﻤﺎﻻت اﻻﺟﺎﺑﺔ  )   اﻻﻳﺪز
  .ﺗﺬآﺮ أآﺜﺮ ﻣﻦ اﺟﺎﺑﺔ واﺣﺪة / ﺷﺠﻊ اﻟﻤﺒﺤﻮث ﻟﻴﺬآﺮ 
 
  ﺣﻤﻰ ﻣﺴﺘﻤﺮة ﻷآﺜﺮ ﻣﻦ ﺷﻬﺮ-1
 ﺐ ﻣﻌﺮوف  اﺳﻬﺎل ﺷﺪﻳﺪ ﻣﺘﻮاﺻﻞ ﺑﺪون ﺳﺒ-2
   ﻧﻘﺼﺎن ﺷﺪﻳﺪ ﻓﻰ اﻟﻮزن-3
  ...................... ﻏﻴﺮ ذﻟﻚ ﺣﺪد -4
  ﺗﻌﺮف /  ﻻﻳﻌﺮف-8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ )  ﻻﻳﻨﻄﺒﻖ -9
 ( ﺑﺎﻻﻳﺪز 
  
  اﻟﺠﺮﺛﻮﻣﺔ اﻟﺒﺘﺴﺒﺐ ﻣﺮض اﻻﻳﺪز ﻧﻮﻋﻬﺎ ﺷﻨﻮ ؟  91
  
  
  ........ ﻏﻴﺮ ذﻟﻚ ﺣﺪد -2 ﻓﻴﺮوس   -1
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ /  ﻟﻢ ﻳﺴﻤﻊاﻟﻤﺒﺤﻮث)  ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز 
    
ﺗﻔﺘﻜﺮى اﻟﺸﺨﺺ اﻟﻌﻨﺪو ﻣﺮض اﻹﻳﺪز ﻣﻤﻜﻦ ﻳﻈﻬﺮ / ﺗﻔﺘﻜﺮ   02
  ﺳﻠﻴﻢ وﻣﻌﺎﻓﻰ آﺄﻧﻮ ﻣﺎ ﻋﻨﺪو أى ﻧﻮع ﻣﻦ اﻟﻤﺮض ؟
  
    ﻻ-2 ﻧﻌﻢ               -1
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز 
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رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  ت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎاﻻﺟﺎﺑﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
ﺗﻔﺘﻜﺮى اﻟﺠﺮﺛﻮﻣﺔ دى أو اﻟﻤﺮض دﻩ ﺑﻨﺘﻘﻞ ﻣﻦ زول / ﺗﻔﺘﻜﺮ  12
  (ﻻ ﺗﺬآﺮ إﺣﺘﻤﺎﻻت اﻹﺟﺎﺑﺔ ) ﻟﻠﺘﺎﻧﻰ آﻴﻒ ؟ 
 
   ﻧﻘﻞ اﻟﺪم-2 اﻟﻌﻼﻗﺎت اﻟﺠﻨﺴﻴﺔ         -1
   ﺛﻮاﻗﺐ اﻟﺠﻠﺪ-4 ﻣﻦ اﻷم ﻟﻠﻄﻔﻞ             -3
  ..……… ذﻟﻚ ﺣﺪد  ﻏﻴﺮ-5
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
 (ﺑﺎﻻﻳﺪز 
  
ﺗﻔﺘﻜﺮى اﻟﺸﺨﺺ ﻣﻤﻜﻦ ﻳﺤﻤﻰ ﻧﻔﺴﻪ ﻣﻦ اﻹﺻﺎﺑﺔ / ﺗﻔﺘﻜﺮ  22
  ﺑﻤﺮض اﻹﻳﺪز آﻴﻒ ؟ 
  ﺷﺠﻊ اﻟﻤﺒﺤﻮث ﻟﻴﺬآﺮ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ واﺣﺪة
 
 ﻳﻘﺘﺼﺮ ﻓﻰ ﻋﻼﻗﺘﻪ اﻟﺠﻨﺴﻴﺔ ﻣﻊ ﺷﺨﺺ -1
 واﺣﺪ ﻏﻴﺮ ﻣﺼﺎب
اﻷﻧﺜﻮى ﻋﻨﺪ /ﻟﺬآﺮى ﻳﺴﺘﻌﻤﻞ اﻟﻌﺎزل ا-2
 ﻳﻤﺘﻨﻊ ﻋﻦ اﻟﻌﻼﻗﺎت اﻟﺠﻨﺴﻴﺔ ﻏﻴﺮ -3  اﻟﺠﻤﺎع
 ﺗﺠﻨﺐ اﻹﺳﺘﻌﻤﺎل اﻟﻤﺸﺘﺮك ﻟﻸدوات -4  اﻟﻤﺸﺮوﻋﺔ
  اﻟﺜﺎﻗﺒﺔ ﻟﻠﺠﻠﺪ/ اﻟﺠﺎرﺣﺔ 
  ..……… ﻏﻴﺮ ذﻟﻚ ﺣﺪد -5
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
 (ﺑﺎﻻﻳﺪز 
  
 ﻧﻘﻞ اﻹﻳﺪز ﺗﻔﺘﻜﺮى ﻋﻀﺔ اﻟﺒﺎﻋﻮض ﻣﻤﻜﻦ ﺗﺘﺴﺒﺐ ﻓﻰ/ ﺗﻔﺘﻜﺮ   32
    ؟
    ﻻ-2 ﻧﻌﻢ               -1
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز 
    
ﺗﻔﺘﻜﺮى ﻣﻤﻜﻦ اﻟﺸﺨﺺ ﻳﺼﺎب ﺑﺎﻹﻳﺪز إذا ﺗﻨﺎول /  ﺗﻔﺘﻜﺮ   42
  اﻟﻄﻌﺎم ﻣﻊ ﺷﺨﺺ ﺁﺧﺮ ﻣﺼﺎب ﺑﺎﻹﻳﺪز  ؟
    ﻻ-2 ﻧﻌﻢ               -1
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ /  اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ) ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز 
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رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
ﺗﻔﺘﻜﺮى ﻣﻤﻜﻦ اﻟﺸﺨﺺ ﻳﺼﺎب ﺑﺎﻹﻳﺪز إذا إﺳﺘﻌﻤﻞ / ﺗﻔﺘﻜﺮ   52
  ﺣﻘﻨﺔ إﺳﺘﻌﻤﻠﻬﺎ ﺷﺨﺺ ﺁﺧﺮ ﻣﺼﺎب ﺑﺎﻹﻳﺪز  ؟
  
    ﻻ-2 ﻧﻌﻢ               -1
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز 
    
ﺗﻔﺘﻜﺮى اﻷم اﻟﺤﺎﻣﻞ وﻋﻨﺪهﺎ ﻣﺮض اﻹﻳﺪز ﻣﻤﻜﻦ /  ﺗﻔﺘﻜﺮ   62
  اﻟﻤﺮض اﻟﻌﻨﺪهﺎ دﻩ ﻳﻨﺘﻘﻞ ﻣﻨﻬﺎ ﻟﻠﺠﻨﻴﻦ ؟
  
    ﻻ-2 ﻧﻌﻢ               -1
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز 
آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻼ إﻧﺘﻘﻞ إذا   
 وأﻣﻼ 82ﻟﻠﺴﺆال رﻗﻢ 
 72اﻟﺨﺎﻧﺎت ﻓﻰ اﻟﺴﺆال 
   .9ﺑﺎﻟﺮﻗﻢ 
  :أﺟﺎﺑﺖ ﺑﻨﻌﻢ ﻓﻰ اﻟﺴﺆال اﻟﺴﺎﺑﻖ أﺳﺄل / إذاأﺟﺎب 72
  اﻹﻧﺘﻘﺎل ﺑﻜﻮن آﻴﻒ ﻣﻦ اﻷم ﻟﻠﺠﻨﻴﻦ ؟
  .ﺷﺠﻊ اﻟﻤﺒﺤﻮث ﻟﻴﺬآﺮ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ 
 
  ﻋﻦ ﻃﺮﻳﻖ اﻟﻤﺸﻴﻤﺔ-1
   ﻋﻨﺪ اﻟﻮﻻدة-2
   ﻋﻦ ﻃﺮﻳﻖ اﻟﺮﺿﺎﻋﺔ-3
  ............. ﺣﺪد  ﻏﻴﺮ ذﻟﻚ-4
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
أﺟﺎﺑﺖ ﺑﻼ ﻓﻰ اﻟﺴﺆال /  أﺟﺎب – ﻻﻳﻨﻄﺒﻖ -9
ﺗﺴﻤﻊ /  أﻋﻼﻩ أو اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ 72
 ﺑﺎﻻﻳﺪز
  
إذا ﻓﻰ زول ﻣﻦ أهﻠﻚ ﺟﺎهـﻮ اﻹﻳﺪز ﻣﻤﻜﻦ ﺗﻤﺎرﺿﻮﻩ ﻣﻌﺎآﻢ   82
    ﻓﻰ اﻟﺒﻴﺖ ؟
    ﻻ-2 ﻧﻌﻢ               -1
  ة ﻣﺘﺄآﺪ/ ﺗﻌﺮف أو ﻏﻴﺮ ﻣﺘﺄآﺪ /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ ) ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز
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ﺗﺄآﻠﻰ / إذا ﻋﺮﻓﺖ إﻧﻪ ﻓﻰ ﺷﺨﺺ ﻣﺼﺎب ﺑﺎﻹﻳﺪز ﻣﻤﻜﻦ ﺗﺄآﻞ   92
  ﻣﻌﺎﻩ ﻓﻰ ﻣﺎﻋﻮن واﺣﺪ ؟
  
  أى ﻣﻌﻨﻰ ﻳﻔﻴﺪ اﻟﻘﺒﻮل .1
 أى ﻣﻌﻨﻰ ﻳﻔﻴﺪ ﻋﺪم اﻟﻘﺒﻮل .2
  ﻣﺘﺄآﺪة / ﺗﻌﺮف أو ﻏﻴﺮ ﻣﺘﺄآﺪ /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ ) ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز
    
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
ﻟﻮ ﻓﻰ ﻃﺎﻟﺐ أو ﻃﺎﻟﺒﺔ ﻣﺼﺎﺑﻴﻦ ﺑﺎﻹﻳﺪز ﻟﻜﻦ ﻟﺴﻊ اﻟﻤﺮض ﻣﺎ  03
ﺗﻔﺘﻜﺮى ﻳﺨﻠﻮهﻢ ﻳﻤﺸﻮا اﻟﻤﺪرﺳﺔ وﻻ / إﺗﻤﻜﻦ ﻣﻨﻬﻢ ﺗﻔﺘﻜﺮ
 أﺟﺎﺑﺖ ﻳﻤﻨﻌﻮهﻢ أﺳﺄل ﻟﻴﻪ ؟/ ﻳﻤﻨﻌﻮهﻢ ؟ إذا أﺟﺎب 
 ﻳﻤﺸﻮا اﻟﻤﺪرﺳﺔ -1
   ﻳﻤﻨﻌﻮهﻢ ﻟﻤﻨﻊ اﻟﻌﺪوى-2
  ............ ﻳﻤﻨﻌﻮهﻢ ﻷﺳﺒﺎب أﺧﺮى ﺣﺪد -3
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
   (ﺑﺎﻻﻳﺪز 
  
ﻟﻮ ﻓﻰ ﻣﻌﻠﻢ أو ﻣﻌﻠﻤﺔ ﻣﺼﺎﺑﻴﻦ ﺑﺎﻹﻳﺪز ﻟﻜﻦ ﻟﺴﻊ اﻟﻤﺮض ﻣﺎ  13
ﻇﻬﺮ ﻋﻠﻴﻬﻢ ﺗﻔﺘﻜﺮى ﻳﺨﻠﻮهﻢ ﻳﻤﺸﻮا اﻟﻤﺪرﺳﺔ وﻻ ﻳﻤﻨﻌﻮهﻢ ؟ 
 أﺟﺎﺑﺖ ﻳﻤﻨﻌﻮهﻢ أﺳﺄل ﻟﻴﻪ ؟/ أﺟﺎب إذا 
  ﻳﻮاﺻﻠﻮا ﺗﻌﻠﻴﻢ اﻟﺘﻼﻣﻴﺬ-1
   ﻳﻤﻨﻌﻮهﻢ اﻟﺘﺪرﻳﺲ ﻟﻤﻨﻊ اﻟﻌﺪوى-2
 ﻳﻤﻨﻌﻮهﻢ اﻟﺘﺪرﻳﺲ ﻷﺳﺒﺎب أﺧﺮى ﺣﺪد -3
  ..................................................
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
 (ﺑﺎﻻﻳﺪز 
  
ﺼﺎب ﺑﺎﻹﻳﺪز وهﻮ ﺑﺎﺋﻊ ﻃﻌﺎم ﺑﺘﺸﺘﺮى ﻣﻨﻪ ﻟﻮ ﻓﻰ ﺷﺨﺺ ﻣ  23
   اﻟﻄﻌﺎم ؟ 
    ﻻ-2 ﻧﻌﻢ               -1
  ﻣﺘﺄآﺪة / ﺗﻌﺮف أو ﻏﻴﺮ ﻣﺘﺄآﺪ /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ ) ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز
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 - ﻻ ﻗﺪر اﷲ – واﻟﺪﻳﻚ أو إﺧﻮاﻧﻚ –إذا  ﻓﻰ واﺣﺪ ﻣﻦ أﺳﺮﺗﻚ   33
  ﺮﺿﻪ ﻣﻦ اﻟﻨﺎس ؟ ﺗﺪﺳﻰ ﻣ/ أﺻﻴﺐ ﺑﺎﻹﻳﺪز ﺑﺘﺤﺎول ﺗﺪس 
 
    ﻻ-2 ﻧﻌﻢ               -1
  ﻣﺘﺄآﺪة / ﺗﻌﺮف أو ﻏﻴﺮ ﻣﺘﺄآﺪ /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ ) ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز
    
  ﺣﺼﻞ ﻋﻤﻠﺖ ﻗﺒﻞ آﺪﻩ أى ﻓﺤﺺ ﻟﻺﻳﺪز ؟  43
 
    ﻻ-2 ﻧﻌﻢ               -1
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
  (ﻳﺪز ﺑﺎﻻ
إذا آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻼ إﻧﺘﻘﻞ   
 وأﻣﻼ 73ﻟﻠﺴﺆال رﻗﻢ 
   . 9ﺟﻤﻴﻊ اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
إذا آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻨﻌﻢ ﻋﻠﻰ اﻟﺴﺆال أﻋﻼﻩ ﻋﻤﻠﺖ اﻟﻔﺤﺺ دﻩ   53
  ﻨﺔ ﻃﻠﺒﺖ ﻣﻨﻚ اﻟﻔﺤﺺ دﻩ ؟ﺑﺮﻏﺒﺘﻚ وﻻ ﻓﻰ ﺟﻬﺔ ﻣﻌﻴ
  
  ﻃﻮاﻋﻴﺔ ﺑﺮﻏﺒﺘﻰ .1
 ﻃﻠﺐ ﻣﻨﻰ ﺑﻮاﺳﻄﺔ ﺟﻬﺔ ﻣﺎ .2
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺗﺴﻤﻊ / اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز او ﻟﻢ ﻳﺠﺮي ﻟﻪ ﻓﺤﺺ 
    
  ﻧﺘﻴﺠﺔ اﻟﻔﺤﺺ آﺎﻧﺖ ﺷﻨﻮ ؟  63
  
  ﻣﺼﺎﺑﺔ/ ﻣﺼﺎب  .1
 ﻏﻴﺮ ﻣﺼﺎﺑﺔ/ ﻏﻴﺮ ﻣﺼﺎب  .2
  ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -8
ﺴﻤﻊ ﺗ/ اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ)  ﻻﻳﻨﻄﺒﻖ -9
  (ﺑﺎﻻﻳﺪز او ﻟﻢ ﻳﺠﺮي ﻟﻪ ﻓﺤﺺ 
    
( إﺗﻄﻌﻨﺖ ﺑﻴﻬﺎ ) ﺣﺼﻞ أﺑﺪا ﻓﻰ ﺣﻴﺎﺗﻚ إﺳﺘﻌﻤﻠﺖ ﺣﻘﻨﺔ   73
  واﻟﺤﻘﻨﻪ دى إﺳﺘﻌﻤﻠﻬﺎ زول ﻗﺒﻠﻚ ؟ 
    ﻻ-2 ﻧﻌﻢ               -1
  ﻣﺘﺄآﺪة / ﺗﻌﺮف أو ﻏﻴﺮ ﻣﺘﺄآﺪ /  ﻻ ﻳﻌﺮف -8
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هﻞ ﺗﻐﻠﻰ اﻟﻤﺤﺎﻗﻦ اﻟﺒﻼﺳﺘﻴﻜﻴﺔ ﻓﻰ اﻟﻮﺣﺪات اﻟﺼﺤﻴﺔ اﻟﺘﻰ   83
  ﺗﺘﺮدد ﻋﻠﻴﻬﺎ ؟
    ﻻ-2 ﻧﻌﻢ               -1
  ﻣﺘﺄآﺪة/ ﺗﻌﺮف أو ﻏﻴﺮ ﻣﺘﺄآﺪ /  ﻻ ﻳﻌﺮف -8
    
ﺣﺼﻞ أﺑﺪا ﻓﻰ ﺣﻴﺎﺗﻚ إﺳﺘﻌﻤﻠﺖ ﻣﻮس ﻟﻠﺤﻼﻗﺔ أو ﻟﺘﻨﻈﻴﻒ   93
اﻟﺠﺴﻢ أو ﺗﻘﻠﻴﻢ اﻷﻇﺎﻓﺮ واﻟﻤﻮس دى آﺎﻧﺖ ﻣﺴﺘﻌﻤﻠﻪ ﺑﻮاﺳﻄﺔ 
  ﺷﺨﺺ ﺁﺧﺮ ؟ ﻳﻌﻨﻰ ﻣﺎ ﺟﺪﻳﺪة
    ﻻ-2 ﻧﻌﻢ               -1
  ﻣﺘﺄآﺪة/ آﺪ ﺗﻌﺮف أو ﻏﻴﺮ ﻣﺘﺄ/  ﻻ ﻳﻌﺮف -8
    
  
  
  ﻣﻌﺮﻓﺔ واﺳﺘﻌﻤﺎل اﻟﻌﺎزل اﻟﺬآﺮي: اﻟﻘﺴﻢ اﻟﺜﺎﻟﺚ  
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
ﺣﺼﻞ ﺳﻤﻌﺖ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى أو ﺷﻔﺘﻪ ؟ أذآﺮ اﻟﻤﺴﻤﻴﺎت   04
  اﻟﻤﺤﻠﻴﺔ إن وﺟﺪت 
  (أﻋﺮض ﺻﻮرة أو ﻣﺠﺴﻢ ﻟﺬﻟﻚ ) 
  ﻻ ﻟﻢ أﺳﻤﻊ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى وﻟﻢ أرﻩ .1
 ﻧﻌﻢ ﺳﻤﻌﺖ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى .2
  ﻧﻌﻢ ﺳﻤﻌﺖ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى ورأﻳﺘﻪ .3
إذا آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻼ إﻧﺘﻘﻞ   
 وأﻣﻼ ﺟﻤﻴﻊ 54ﻟﻠﺴﺆال 
   .99اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ 
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
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رأى / إﻧﻬﺎ ﺳﻤﻊ /  أﻋﻼﻩ أﻧﻪ 04ذآﺮت ﻓﻰ اﻟﺴﺆال / إذا ذآﺮ  14
  :اﻟﻌﺎزل اﻟﺬآﺮى ، أﺳﺄل 
  رأﻳﺘﻪ أو ﺳﻤﻌﺖ ﻋﻨﻪ ﻣﻦ وﻳﻦ ؟
  ﻻ ﺗﺬآﺮ اﻹﺣﺘﻤﺎﻻت
 اﻟﻤﺒﺤﻮﺛﺔ ﻟﻴﺬآﺮ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ واﺣﺪة/ ﺷﺠﻊ اﻟﻤﺒﺤﻮث 
    اﻟﺘﻠﻔﺰﻳﻮن-2 اﻹذاﻋﺔ          -1 
  اﻷهﻞ/   اﻟﻤﻌﺎرف -3
  اﻟﻜﺘﺐ/ ﻟﻤﺠﻼت ا/  اﻟﺼﺤﻒ -4 
  ﻣﺮآﺰ ﺗﻨﻈﻴﻢ اﻷﺳﺮة/   اﻟﻮﺣﺪة اﻟﺼﺤﻴﺔ -5
اﻟﻘﺮﻧﺎء      /  اﻷﺻﺪﻗﺎء -7  اﻟﺼﻴﺪﻟﻴﺔ        -6
    ﻻ أذآﺮ اﻟﻤﺼﺪر-8
  ............  ﻏﻴﺮ ذﻟﻚ ﺣﺪد -9
/ اﻟﻤﺒﺤﻮﺛﺔ ﻟﻢ ﻳﺮ / اﻟﻤﺒﺤﻮث )   ﻻ ﻳﻨﻄﺒﻖ -99
  (ﻟﻢ ﻳﺴﻤﻊ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى 
  
ﻣﺠﺘﻤﻌﻜﻢ دﻩ هﻨﺎ ﻋﺎدة / ﻋﻨﺪك ﻓﻜﺮة اﻟﻨﺎس ﻓﻰ اﻟﻤﻨﻄﻘﺔ دى  24
  ﺑﺘﺤﺼﻠﻮا ﻋﻠﻰ اﻟﻌﺎزل اﻟﺬآﺮى ﻣﻦ وﻳﻦ ؟
  ﻻ ﺗﺬآﺮ اﻹﺣﺘﻤﺎﻻت
  اﻟﻤﺒﺤﻮﺛﺔ ﻟﻴﺬآﺮ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ واﺣﺪة/ ﺷﺠﻊ اﻟﻤﺒﺤﻮث 
 
   اﻟﺴﻮق-2 اﻟﺪآﺎآﻴﻦ                -1
   اﻟﻤﺴﺘﺸﻔﻰ-4 اﻟﺼﻴﺪﻟﻴﺎت             -3
   ﻣﺮآﺰ ﺗﻨﻈﻴﻢ اﻷﺳﺮة-5
  اﻟﻮﺣﺪة اﻟﺼﺤﻴﺔ/ اﻟﻤﺮآﺰ اﻟﺼﺤﻰ-6
   ﻋﻴﺎدة ﺧﺎﺻﺔ-8دة اﻟﻤﻨﻈﻤﺎت         ﻋﻴﺎ-7
  اﻷﺻﺪﻗﺎء واﻟﻤﻌﺎرف/  اﻟﺰﻣﻼء -9
  .................... ﻏﻴﺮ ذﻟﻚ ﺣﺪد -01
    ﻻ ﻳﻌﺮف -88
/ اﻟﻤﺒﺤﻮﺛﺔ ﻟﻢ ﻳﺮ / اﻟﻤﺒﺤﻮث ) ﻻ ﻳﻨﻄﺒﻖ  -99
 (ﻟﻢ ﻳﺴﻤﻊ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى 
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  ﺣﺼﻞ ﻗﺒﻞ آﺪﻩ ؟  34
  "إذا اﻟﻤﺒﺤﻮث ذآﺮ " إﺳﺘﻌﻤﻠﺖ اﻟﻌﺎزل اﻟﺬآﺮى  •
إذا آﺎﻧﺖ "  ﺑﺈﺳﺘﻌﻤﺎل اﻟﻌﺎزل اﻟﺬآﺮى ﺗﻤﺖ اﻟﻤﺠﺎﻣﻌﻪ •
  "اﻟﻤﺒﺤﻮﺛﺔ أﻧﺜﻰ 
   ﻻ-2 ﻧﻌﻢ                 -1
/ اﻟﻤﺒﺤﻮﺛﺔ ﻟﻢ ﻳﺮ / اﻟﻤﺒﺤﻮث )   ﻻ ﻳﻨﻄﺒﻖ -99
  (ﻟﻢ ﻳﺴﻤﻊ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى 
  
إذا آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻼ إﻧﺘﻘﻞ   
 وأﻣﻼ 54ﻟﻠﺴﺆال رﻗﻢ 
   .99ﺟﻤﻴﻊ اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ 
  
  
  
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  ﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎاﻻﺟﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
   أﻋﻼﻩ ﺑﻨﻌﻢ أﺳﺄل ﻟﻴﻪ ؟ 34إذا آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﻋﻠﻰ اﻟﺴﺆال  44
  إﺳﺘﻌﻤﻠﺘﻪ ﻟﻴﻪ ؟
 
  ﻟﻤﻨﻊ اﻹﺻﺎﺑﺔ ﺑﺎﻹﻳﺪز-1
 ﻟﻤﻨﻊ اﻹﺻﺎﺑﺔ ﺑﺎﻷﻣﺮاض اﻟﺠﻨﺴﻴﺔ -2
   ﻟﻤﻨﻊ اﻟﺤﻤﻞ-3  واﻟﺘﻨﺎﺳﻠﻴﺔ
   إﺳﺘﺠﺎﺑﺔ ﻟﻄﻠﺐ اﻟﻄﺮف اﻵﺧﺮ-4
  ……………ﻏﻴﺮ ذﻟﻚ ﺣﺪد -5
/ اﻟﻤﺒﺤﻮﺛﺔ ﻟﻢ ﻳﺮ / اﻟﻤﺒﺤﻮث ) ﻻ ﻳﻨﻄﺒﻖ  -99
 (ﻟﻢ ﻳﺴﻤﻊ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى 
  
ﻟﻐﻴﺮ " هﻞ ﺗﻤﺎرس اﻟﺠﻨﺲ اﻵن أو آﻨﺖ ﺗﻤﺎرﺳﻪ ﻓﻰ اﻟﺴﺎﺑﻖ ؟   54
  "ﺗﻘﺺ ﻋﻦ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع " " اﻟﻤﺘﺰوﺟﻴﻦ 
أو آﻨﺖ ﺗﻤﺎرﺳﻪ ﻓﻰ اﻟﺴﺎﺑﻖ / أو هﻞ ﺗﻤﺎرس اﻟﺠﻨﺲ اﻵن 
اﻟﻤﺒﺤﻮﺛﺔ / ﻴﺔ إن آﺎن اﻟﻤﺒﺤﻮث وﻟﻜﻦ ﺧﺎرج اﻟﻌﻼﻗﺔ اﻟﺰوﺟ
  " .ﻟﻠﻤﺘﺰوﺟﻴﻦ " ﻣﺘﺰوﺟﺔ ؟ / ﻣﺘﺰوج 
  (ﻟﻐﻴﺮ اﻟﻤﺘﺰوﺟﻴﻦ ) ﻻ اﻵن وﻻ ﺳﺎﺑﻘًﺎ . ﻻ  .1
ﺳﻮاء ﻟﻠﻤﺘﺰوﺟﻴﻦ أو ﻏﻴﺮ ) ﻧﻌﻢ اﻵن  .2
ﻟﻠﻤﺘﺰوﺟﻴﻦ وﻏﻴﺮ ) ﻧﻌﻢ ﻟﻜﻦ ﻓﻰ اﻟﺴﺎﺑﻖ  .3 (اﻟﻤﺘﺰوﺟﻴﻦ 
  ﻧﻌﻢ ﻟﻜﻦ ﻗﺒﻞ اﻟﺰواج .4 (اﻟﻤﺘﺰوﺟﻴﻦ 
إذا آﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻼ إﻧﺘﻘﻞ   
 وأﻣﻼ 25ﻟﻠﺴﺆال رﻗﻢ 
   .99ﺟﻤﻴﻊ اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ 
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إذا ذآﺮ اﻟﻤﺒﺤﻮث أﻧﻪ ﻳﻤﺎرس اﻟﺠﻨﺲ اﻵن أو ﻓﻰ اﻟﺴﺎﺑﻖ أﺳﺄل   64
ﺑﺪﻳﺘﻰ ﻓﻴﻬﺎ ﻣﻤﺎرﺳﺔ / ﻋﻤﺮك آﺎن آﻢ ﺳﻨﻪ ﻓﻰ أول ﻣﺮة ﺑﺪﻳﺖ :
  ؟" ﻟﻐﻴﺮ اﻟﻤﺘﺰوﺟﻴﻦ " اﻟﺠﻨﺲ 
  ؟" ﻟﻠﻤﺘﺰوﺟﻴﻦ " أو ﻣﻤﺎرﺳﺘﻪ ﺧﺎرج اﻟﻌﻼﻗﺔ اﻟﺰوﺟﻴﺔ 
د أآﺘﺐ اﻟﻌﻤﺮ ﺑﺎﻟﺴﻨﻮات اﻟﻜﺎﻣﻠﺔ ﻓﻰ اﻟﻌﻤﻮ
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ "   ﻻ ﻳﻨﻄﺒﻖ -99  اﻟﻤﻘﺎﺑﻞ
  "ﻣﻤﺎرﺳﺔ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع 
    
إذا أﻓﺎد اﻟﻤﺒﺤﻮث ﻣﻤﺎرﺳﺔ اﻟﺠﻨﺲ ﻓﻰ اﻟﺴﺆال أﻋﻼﻩ ، أﺳﺄل   74
  ﺑﺘﻤﺎرﺳﻰ اﻟﺠﻨﺲ ﻣﻊ آﻢ ﻧﻔﺮ ؟/ اﻵن أو ﻓﻰ اﻟﺴﺎﺑﻖ ﺑﺘﻤﺎرس 
  
  أآﺘﺐ ﻋﺪد اﻷﺷﺨﺎص ﻓﻰ اﻟﻌﻤﻮد اﻟﻤﻘﺎﺑﻞ
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ "   ﻻ ﻳﻨﻄﺒﻖ -99
  "ﻤﺎرﺳﺔ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع ﻣ
    
  اﻵن أو ﺳﺎﺑﻘًﺎ ﺑﺘﻤﺎرس اﻟﺠﻨﺲ ﻣﻊ ﻣﻨﻮ ؟  84
  
  اﻟﺬآﻮر ﻓﻘﻂ-2 اﻹﻧﺎث ﻓﻘﻂ          -1
   اﻟﺬآﻮر واﻹﻧﺎث-3
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ "   ﻻ ﻳﻨﻄﺒﻖ -99
  "ﻣﻤﺎرﺳﺔ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع 
    
  
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /ﺟﺎﺑﺔرﻗﻢ اﻻ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
ﻟﻐﻴﺮ " ﺷﻨﻮ اﻟـﺪاﻓﻊ اﻵن أو ﺳﺎﺑﻘـًﺎ اﻟﺨﻼك ﺗﻤﺎرس اﻟﺠﻨﺲ  94
  ؟" ﻟﻐﻴﺮ اﻟﻤﺘﺰوﺟﻴﻦ " أو ﻣﻤﺎرﺳﺘﻪ ﺧﺎرج اﻟﻌﻼﻗﺔ اﻟﺰوﺟﻴﺔ   ؟" اﻟﻤﺘﺰوﺟﻴﻦ 
 
   اﻟﻤﺘﻌﺔ-2 أﺳﺎب إﻗﺘﺼﺎدﻳﺔ          -1
   وﻗﺖ اﻟﻔﺮاغ-4 ﺗﻘﻠﻴﺪ اﻟﻘﺮﻧﺎء واﻷﺻﺪﻗﺎء    -3
  ........ ﻏﻴﺮ ذﻟﻚ ﺣﺪد -5
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ "   ﻻ ﻳﻨﻄﺒﻖ -99
 "ﻣﻤﺎرﺳﺔ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع 
  
/ اﻟﻨﺎس اﻟﺒﺘﻤﺎرس ﻣﻌﺎهﻢ اﻟﺠﻨﺲ دﻳﻞ ﺑﻤﺎرﺳﻮا اﻟﺠﻨﺲ   05
  اﻟﺪﻋﺎرة آﻤﻬﻨﺔ وﻣﻊ أى زول ؟
  
   ﻻ ﻳﻌﺮف-3 ﻻ           -2 ﻧﻌﻢ             -1
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ "   ﻻ ﻳﻨﻄﺒﻖ -99
   "ﻣﻤﺎرﺳﺔ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع
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" ﺧﻼل اﻟﺴﻨﺔ اﻟﻔﺎﺗﺖ أو ﻓﻰ ﺁﺧﺮ ﻣﺮة ﻣﺎرﺳﺖ ﻓﻴﻬﺎ اﻟﺠﻨﺲ   15
ﺣﺼﻞ " ﺗﻘّﺺ ﻋﻦ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع ﻟﻐﻴﺮ اﻟﻤﺘﺰوﺟﻴﻦ 
إﺳﺘﻌﻤﻠﺖ اﻟﻌﺎزل اﻟﺬآﺮى أو ﺗﻤﺖ اﻟﻤﺠﺎﻣﻌﺔ ﺑﺈﺳﺘﻌﻤﺎل اﻟﻌﺎزل 
  اﻟﺬآﺮى إذا آﺎﻧﺖ اﻟﻤﺒﺤﻮﺛﺔ أﻧﺜﻰ ؟
  ﻳﻤﻜﻦ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ** 
 ﻧﻌﻢ ﺗﻢ إﺳﺘﻌﻤﺎل اﻟﻌﺎزل اﻟﺬآﺮى ﻓﻰ ﺁﺧﺮ -1
 ﻧﻌﻢ ﻳﺴﺘﻌﻤﻞ ﺑﻄﺮﻳﻘﺔ ﻣﻨﺘﻈﻤﺔ ﺧﻼل اﻟﻌﺎم -2 ﺎرﺳﺔﻣﻤ
   ﻧﻌﻢ ﻳﺴﺘﻌﻤﻞ أﺣﻴﺎﻧًﺎ ﺧﻼل اﻟﻌﺎم اﻟﺴﺎﺑﻖ-3  اﻟﺴﺎﺑﻖ
  ﻳﻤﺎرس اﻟﺠﻨﺲ داﺋﻤًﺎ ﺑﺪون إﺳﺘﻌﻤﺎل اﻟﻌﺎزل-4
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﺒﻖ ﻟﻪ "   ﻻ ﻳﻨﻄﺒﻖ -99
  "ﻣﻤﺎرﺳﺔ اﻟﺠﻨﺲ ﻏﻴﺮ اﻟﻤﺸﺮوع 
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  اﻻﺻﺎﺑﺔ ﺑﺎﻻﻣﺮاض اﻟﻤﻨﻘﻮﻟﺔ ﺟﻨﺴﻴﺎ: اﻟﻘﺴﻢ اﻟﺮاﺑﻊ  
 
رﻗﻢ 
 ﺴﺆالاﻟ
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
إﺷﺘﻜﻴﺖ أو آﻨﺖ ﺑﺘﺸﺘﻜﻰ ( اﻵن وﻻ ﻓﻰ اﻟﻤﺎﺿﻰ ) ﺣﺼﻞ أﺑﺪا  25
  :اﻻﻋﺮاض اﻵﺗﻴﺔ / ﻣﻦ أى واﺣﺪة ﻣﻦ اﻹﻟﺘﻬﺎﺑﺎت 
  أذآﺮ اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ اﻟﻤﻘﺎﺑﻠﺔ واﺣﺪة ﺗﻠﻮ اﻷﺧﺮى ؟
 ل ﺣﻴﺎة اﻟﻤﺒﺤﻮثو ﺗﻘﺺ ﻋﻨﻬﺎ ﺧﻼ
  ( ذآﺮﻳﺔ )  إﻓﺮازات إﺣﻠﻴﻠﻴﺔ -1
 إﻓﺮازات ﻣﻬﺒﻠﻴﺔ ﻣﺘﻐﻴﺮة ﻓﻰ اﻟﻠﻮن ، اﻟﺮاﺋﺤﺔ ، أو -2
/ اﻟﺴﺒﻴﻞ / أآﻮﻟﺔ ﻓﻰ اﻟﻌﻀﻮ اﻟﺘﻨﺎﺳﻠﻰ /  ﺣﻜﺔ -3  اﻟﻜﻤﻴﺔ
  ﺣﺮارة ﻓﻰ اﻟﻌﻀﻮ اﻟﺘﻨﺎﺳﻠﻰ( ﻋﻮارة )  ﻗﺮﺣﺔ -4  ﻣﺠﺮى اﻟﺒﻮل
   ﻟﻢ ﻳﺸﺘﻚ اﻟﻤﺒﺤﻮث ﻣﻦ اي ﻣﻤﺎ ذآﺮ اﻋﻼﻩ-99
ﺤﻮث إذا ﻟﻢ ﻳﺸﺘﻚ اﻟﻤﺒ 
ﻣﻦ ﺟﻤﻴﻊ اﻟﻤﺸﺎآﻞ 
اﻟﺼﺤﻴﺔ إﻧﺘﻘﻞ ﻟﻠﺴﺆال 
 وأﻣﻼ ﺟﻤﻴﻊ 95رﻗﻢ 
  .99اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ 
ﻟﻮ اﻵن أو ﻓﻰ اﻟﻤﺎﺿﻰ اﻟﻤﻌﺎﻧﺎة ﻣﻦ اﻹﻟﺘﻬﺎﺑﺎت دى إﺳﺘﻤﺮت   35
  ﻣﻌﺎك ﻣﺪة ﻗﺪر ﺷﻨﻮ ؟
  
أآﺘﺐ اﻟﻔﺘﺮة ﺑﺎﻟﺴﻨﻮات ﻓﻰ اﻟﻌﻤﻮد اﻟﻤﻘﺎﺑﻞ إذا ﺳﻨﺔ أو 
   (1) أﻗﻞ ﻣﻦ ﺳﻨﺔ أآﺘﺐ 
ﺼﺐ ﺑﺄى ﻣﻦ اﻟﻤﺒﺤﻮث ﻟﻢ ﻳ"   ﻻ ﻳﻨﻄﺒﻖ -99
   "25اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ ﻓﻰ اﻟﺴﺆال 
    
أو آﻨﺖ ﺑﺘﺎﺧﺪ أى ﻧﻮع ﻣﻦ / ﻟﻮ اﻵن أو ﻓﻰ اﻟﻤﺎﺿﻰ هﻞ ﺑﺘﺎﺧﺪ  45
 اﻟﻌﻼﺟﺎت اﻟﻄﺒﻴﺔ اﻟﺤﺪﻳﺜﺔ ؟
   ﻻ-2 ﻧﻌﻢ               -1
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺼﺐ ﺑﺄى ﻣﻦ "   ﻻ ﻳﻨﻄﺒﻖ -99
  "25اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ ﻓﻰ اﻟﺴﺆال 
  
/  أو آﻨﺖ ﺗﻤﺎرﺳﻪ ﺗﻤﺎرﺳﻰ اﻟﺠﻨﺲ اﻵن/ هﻞ ﺗﻤﺎرس   55
داﺧﻞ أو ) ﺗﻤﺎرﺳﻴﻪ ﻓﻰ اﻟﻤﺎﺿﻰ ﻣﻊ وﺟﻮد هﺬﻩ اﻻﻋﺮاض ؟ 
  (ﺧﺎرج اﻟﻌﻼﻗﺔ اﻟﺰوﺟﻴﺔ 
   ﻻ-2 ﻧﻌﻢ               -1
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺼﺐ ﺑﺄى ﻣﻦ "   ﻻ ﻳﻨﻄﺒﻖ -99
   "25اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ ﻓﻰ اﻟﺴﺆال 
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رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /ﻗﻢ اﻻﺟﺎﺑﺔر  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
هﻞ ( اﻵن أو ﻓﻰ اﻟﻤﺎﺿﻰ ) ﻓﻰ وﺟﻮد هﺬﻩ اﻻﻋﺮاض   65
إن آﺎﻧﺖ ) إﺳﺘﻌﻤﻠﺖ اﻟﻌﺎزل اﻟﺬآﺮى أو ﻃﻠﺒﺘﻰ اﺳﺘﻌﻤﺎﻟﻪ 
  ﻋﻨﺪ اﻟﻤﻤﺎرﺳﺔ اﻟﺠﻨﺴﻴﺔ ؟( اﻟﻤﺒﺤﻮﺛﻪ أﻧﺜﻰ 
  (أﻇﻬﺮ ﺻﻮرة أو ﻣﺠﺴﻢ ﻟﻠﻌﺎزل اﻟﺬآﺮى ) 
  
أﻃﻠﺐ إﺳﺘﻌﻤﺎل / ﻧﻌﻢ أﻧﺎ ﻣﺼﺎب اﻵن وأﺳﺘﻌﻤﻞ  .1
ﻻ أﻃﻠﺐ / ﻧﻌﻢ أﻧﺎ ﻣﺼﺎب اﻵن وﻟﻜﻦ ﻻ أﺳﺘﻌﻤﻞ  .2  ﻟﻌﺎزلا
/ ﻧﻌﻢ آﻨﺖ ﻣﺼﺎب ﻓﻰ اﻟﻤﺎﺿﻰ وإﺳﺘﻌﻤﻠﺖ  .3 إﺳﺘﻌﻤﺎﻟﻪ
 ﻃﻠﺒﺖ إﺳﺘﻌﻤﺎل اﻟﻌﺎزل
/ ﻧﻌﻢ آﻨﺖ ﻣﺼﺎب ﻓﻰ اﻟﻤﺎﺿﻰ ﻟﻜﻦ ﻟﻢ أﺳﺘﻌﻤﻞ  .4
 أﻃﻠﺐ إﺳﺘﻌﻤﺎل اﻟﻌﺎزل
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺼﺐ ﺑﺄى ﻣﻦ "   ﻻ ﻳﻨﻄﺒﻖ -99
   "25اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ ﻓﻰ اﻟﺴﺆال 
    
ﺒﺤﻮث ﻳﺴﺘﻌﻤﻞ أو ﻻ ﻳﺴﺘﻌﻤﻞ اﻟﻌﺎزل اﻟﺬآﺮى إذا آﺎن اﻟﻤ 75
  ﻓﻰ اﻟﺴﺆال أﻋﻼﻩ أﺳﺄل ﻟﻴﻪ ؟
  ﻳﻤﻜﻦ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ •
 
   ﻣﻜﻠﻒ -3 ﻣﺎ ﻣﻮﺟﻮد    -2 ﺑﺪون ﺳﺒﺐ    -1
  اﻟﻤﻤﺎرس/ اﻟﺰوﺟﻪ /  رﻓﺾ اﻟﺰوج -4
  (ﺣﺪد )  ﻳﺴﺘﻌﻤﻞ ﻣﻮاﻧﻊ أﺧﺮى -5
   ﻟﻠﻮﻗﺎﻳﺔ ﻣﻦ اﻹﻳﺪز واﻷﻣﺮاض اﻟﺘﻨﺎﺳﻠﻴﺔ-6
   ﻟﻤﻨﻊ اﻟﺤﻤﻞ-7
  .......................... ﻏﻴﺮ ذﻟﻚ ﺣﺪد -8
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺴﻤﻊ ﺑﺎﻟﻌﺎزل اﻟﺬآﺮى )  ﻻ ﻳﻨﻄﺒﻖ -99
أو ﻟﻢ ﻳﺼﺐ ﺑﺄى ﻣﻦ اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ ﻓﻰ / و 
   (25اﻟﺴﺆال 
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رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
اﻻﻋﺮاض دى اﻵن أو ﻓﻰ اﻟﻤﺎﺿﻰ / ﺑﺨﺼﻮص اﻹﻟﺘﻬﺎﺑﺎت  85
  ﺣﺼﻞ أﺑﺪا ﻋﻤﻠﺖ اﻟﺤﺎﺟﺎت دى ؟
  إﻗﺮأ اﻹﺟﺎﺑﺎت اﻟﻤﻘﺎﺑﻠﺔ اﻟﻮاﺣﺪة ﺗﻠﻮ اﻷﺧﺮى
  ﻳﻤﻜﻦ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ •
  
 
ﻣﺴﺘﺸﻔﻰ ، ﻣﺮآﺰ )  ﻣﺸﻴﺖ ﻟﻮﺣﺪة ﺻﺤﻴﺔ ﺣﻜﻮﻣﻴﺔ -1
   ﻣﺸﻴﺖ ﻟﻮﺣﺪة ﺻﺤﻴﺔ ﻣﻠﺤﻘﺔ ﺑﻤﻜﺎن اﻟﻌﻤﻞ-2 (ﺻﺤﻰ 
   إﺳﺘﺸﺮت ﻃﺒﻴﺐ ﻓﻰ ﻋﻴﺎدة ﺧﺎﺻﺔ-3
   ﺗﺠﺎرﻳﺔ/ إﺗﺼﻠﺖ ﺑﺼﻴﺪﻟﻴﺔ ﺧﺎﺻﺔ -4
  اﻟﺘﻘﻠﻴﺪى/  إﺳﺘﻌﻤﻠﺖ اﻟﻌﻼج اﻟﺒﻠﺪى -5
   إﺳﺘﻌﻤﻠﺖ اﻟﻌﺎزل اﻟﺬآﺮى-6
   ﻋﻤﻠﺖ ﻋﻼج ﺧﺎص ﺑﺮاك ﻓﻰ اﻟﺒﻴﺖ-7
   أوﻗﻔﺖ ﻣﻤﺎرﺳﺔ اﻟﺠﻨﺲ-8
اﻷﺷﺨﺎص اﻟﺬﻳﻦ ﻳﻤﺎرﺳﻮن /  أﺧﺒﺮت اﻟﺸﺨﺺ -9
    أﺧﺒﺮت اﻟﺰﻣﻼء واﻟﻘﺮﻧﺎء واﻷﺻﺪﻗﺎء-01  ﻣﻌﻚ اﻟﺠﻨﺲ
 أم ، أب ، أخ)ﺑﻌﺾ أﻓﺮاد اﻟﻌﺎﺋﻠﺔ /  أﺧﺒﺮت أﺣﺪ -11
  (، أﺧﺖ ، زوج ، زوﺟﻪ 
  ...................... ﻏﻴﺮ ذﻟﻚ ﺣﺪد -21
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺼﺐ ﺑﺄى ﻣﻦ "   ﻻ ﻳﻨﻄﺒﻖ -99
  "25اﻟﻤﺸﺎآﻞ اﻟﺼﺤﻴﺔ ﻓﻰ اﻟﺴﺆال 
  
  
  
  اﻻﻋﻼم و اﻻﺗﺼﺎل: اﻟﻘﺴﻢ اﻟﺨﺎﻣﺲ  
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رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
  ﻧﻌﻢ رادﻳﻮ ﻓﻘﻂ .1  أو ﺗﻠﻔﺰﻳﻮن/ هﻞ ﻟﺪﻳﻜﻢ رادﻳﻮ و   95
 ﻧﻌﻢ ﺗﻠﻔﺰﻳﻮن ﻓﻘﻂ .2
 ﻧﻌﻢ رادﻳﻮ وﺗﻠﻔﺰﻳﻮن .3
  ﻻ ﻧﻤﻠﻚ ﻻ رادﻳﻮ وﻻ ﺗﻠﻔﺰﻳﻮن .4
إذا أﺟﺎب اﻟﻤﺒﺤﻮث ﺑﺄن   
ﻟﻴﺲ ﻟﺪﻳﻬﻢ ﻻ رادﻳﻮ وﻻ 
ﺗﻠﻔﺰﻳﻮن إﻧﺘﻘﻞ ﻟﻠﺴﺆال رﻗﻢ 
 وأﻣﻼ ﺟﻤﻴﻊ اﻟﺨﺎﻧﺎت 46
   .9ﺑﺎﻟﺮﻗﻢ 
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  ﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎاﻻﺟ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
ﺗﺴﺘﻤﻌﻰ / هﻞ ﺗﺴﺘﻤﻊ : إذا ذآﺮ أن ﻟﺪﻳﻬﻢ رادﻳﻮ ، أﺳﺄل  06
 ﻣﻤﻜﻦ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ  ﻟﻺذاﻋﺔ
  ﻧﻌﻢ اﻟﻮﻻﺋﻴﺔ-2 ﻧﻌﻢ اﻟﻘﻮﻣﻴﺔ           -1
   إذاﻋﺎت ﻋﺎﻟﻤﻴﺔ-4 ﻧﻌﻢ اﻟﻮﻻﺋﻴﺔ واﻟﻘﻮﻣﻴﺔ   -3
  ﺴﺘﻤﻊ ﻟﻺذاﻋﺔ ﻟﺪﻳﻬﻢ رادﻳﻮ وﻻ ﻳ-5
 (ﻟﻴﺲ ﻟﺪﻳﻬﻢ رادﻳﻮ )  ﻻ ﻳﻨﻄﺒﻖ -9
  
  ﺑﺘﺴﻤﻌﻰ ﻓﻴﻬﻮ اﻹذاﻋﺔ ﻣﺘﻴﻦ ؟/ أآﺜﺮ وآﺖ ﺑﺘﺴﻤﻊ   16
  (إﺟﺎﺑﺔ واﺣﺪة ﻓﻘﻂ ) ﻓﻰ اﻟﺼﺒﺎح وﻻ ﻓﻰ اﻟﻤﺴﺎء 
  أدﺧﻞ اﻟﺮﻗﻢ اﻟﻤﻨﺎﺳﺐ وأآﺘﺐ إﺳﻢ اﻟﺒﺮﻧﺎﻣﺞ
  
 ﺑﺮﻧﺎﻣﺞ ﻗﻮﻣﻰ ﺻﺒﺎﺣﻰ .1
 ﺑﺮﻧﺎﻣﺞ ﻗﻮﻣﻰ ﻣﺴﺎﺋﻰ .2
  ﺑﺮﻧﺎﻣﺞ وﻻﺋﻰ ﺻﺒﺎﺣﻰ .3
 ﺑﺮﻧﺎﻣﺞ وﻻﺋﻰ ﻣﺴﺎﺋﻰ .4
 ﺎت ﻋﺎﻟﻤﻴﺔإذاﻋ .5
  (ﻻ ﻳﺴﺘﻤﻊ ﻟﻪ / ﻻ ﻳﻤﺘﻠﻚ رادﻳﻮ ) ﻻ ﻳﻨﻄﺒﻖ 
ﻻ ) ﻣﻜﺎن اﻟﺮﻗﻢ وأآﺘﺐ  ( 9) أآﺘﺐ اﻟﺮﻗﻢ 
  ﺑﺎﻟﺤﺮوف ﺗﺤﺖ إﺳﻢ اﻟﺒﺮﻧﺎﻣﺞ( ﻳﻨﻄﺒﻖ 
  رﻗﻢ اﻟﺒﺮﻧﺎﻣﺞ
  ..................
  إﺳﻢ اﻟﺒﺮﻧﺎﻣﺞ
  ...............
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  :اﻟﻤﺒﺤﻮﺛﻪ ﺑﺄن ﻟﺪﻳﻬﻢ ﺗﻠﻔﺰﻳﻮن ، أﺳﺄل / إذا أﺟﺎب اﻟﻤﺒﺤﻮث  26
   ﺑﺘﺸﺎهﺪى اﻟﺘﻠﻔﺰﻳﻮن ؟/هﻞ ﺑﺘﺸﺎهﺪ 
  ﻳﻤﻜﻦ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ
 
  ﻧﻌﻢ اﻹرﺳﺎل اﻟﻘﻮﻣﻰ-1
   ﻧﻌﻢ اﻹرﺳﺎل اﻟﻮﻻﺋﻰ-2
   ﻧﻌﻢ اﻻرﺳﺎل اﻟﻘﻮﻣﻲ و اﻟﻮﻻﺋﻲ-3
   ﻧﻌﻢ ﺑﺮاﻣﺞ ﻓﻀﺎﺋﻴﺎت-4
   ﻟﺪﻳﻬﻢ ﺗﻠﻔﺰﻳﻮن وﻻ ﻳﺸﺎهﺪ اﻟﺒﺮاﻣﺞ-5
 (ﻟﻴﺲ ﻟﺪﻳﻬﻢ ﺗﻠﻔﺰﻳﻮن )   ﻻ ﻳﻨﻄﺒﻖ -9
إذا أﺟﺎب اﻟﻤﺒﺤﻮث ﺑﺄن  
ﻟﻴﺲ ﻟﺪﻳﻬﻢ ﺗﻠﻔﺰﻳﻮن إﻧﺘﻘﻞ 
 وأﻣﻼ 46ﻠﺴﺆال رﻗﻢ ﻟ
  .9ﺟﻤﻴﻊ اﻟﺨﺎﻧﺎت ﺑﺎﻟﺮﻗﻢ 
  
  
  
  
  
  
  
  
  
 
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
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  ﺑﺘﺸﺎهﺪى ﻓﻴﻬﻮ اﻟﺘﻠﻔﺰﻳﻮن ﻣﺘﻴﻦ ؟/ أآﺜﺮ وآﺖ ﺑﺘﺸﺎهﺪ   36
  (إﺟﺎﺑﺔ واﺣﺪة ﻓﻘﻂ ) ﻓﻰ اﻟﺼﺒﺎح وﻻ ﻓﻰ اﻟﻤﺴﺎء 
  
 ﻗﻮﻣﻰ ﺻﺒﺎﺣﻰﺑﺮﻧﺎﻣﺞ  .1
 ﺑﺮﻧﺎﻣﺞ ﻗﻮﻣﻰ ﻣﺴﺎﺋﻰ .2
 ﺑﺮﻧﺎﻣﺞ وﻻﺋﻰ ﺻﺒﺎﺣﻰ .3
 ﺑﺮﻧﺎﻣﺞ وﻻﺋﻰ ﻣﺴﺎﺋﻰ .4
 ﺑﺮاﻣﺞ ﻓﻀﺎﺋﻴﺔ ﺻﺒﺎﺣﻴﺔ .5
 ﺑﺮاﻣﺞ ﻓﻀﺎﺋﻴﺔ ﻣﺴﺎﺋﻴﺔ .6
/ ﻻ ﻳﻤﺘﻠﻚ ﺗﻠﻔﺰﻳﻮن أو ﻻ ﻳﺸﺎهﺪ ) ﻻ ﻳﻨﻄﺒﻖ 
ﻣﻜﺎن  ( 9) أآﺘﺐ اﻟﺮﻗﻢ ( ﺗﺸﺎهﺪ اﻟﺘﻠﻔﺰﻳﻮن 
ﺑﺎﻟﺤﺮوف ﺗﺤﺖ ( ﻻ ﻳﻨﻄﺒﻖ ) اﻟﺮﻗﻢ وأآﺘﺐ 
  إﺳﻢ اﻟﺒﺮﻧﺎﻣﺞ
  رﻗﻢ اﻟﺒﺮﻧﺎﻣﺞ
  ..................
  إﺳﻢ اﻟﺒﺮﻧﺎﻣﺞ
  ...............
  
) ﺣﺼﻞ ﻗﺒﻞ آﺪﻩ ﺗﺤﺼﻠﺖ ﻋﻠﻰ ﻣﻮاد ﺗﻌﻠﻴﻤﻴﺔ ﻣﻄﺒﻮﻋﻪ   46
 ﻋﻦ ﻣﺮض اﻹﻳﺪز ؟( ﻣﺠﻼت ، ﻣﻠﺼﻘﺎت ، آﺘﻴﺒﺎت ، ﻧﺸﺮات 
       ﻻ-2 ﻧﻌﻢ                      -1
ﺗﻔﺘﻜﺮى ﺷﻨﻮ أﻧﺴﺐ اﻟﻄﺮق اﻟﻤﻤﻜﻦ ﻧﺸﺮح / ﺗﻔﺘﻜﺮ  • 56
  ﺬآﺮ اﻹﺣﺘﻤﺎﻻتﺑﻴﻬﺎ ﻟﻠﻨﺎس ﻋﻦ ﻣﺮض اﻹﻳﺪز ؟ ﻻ ﺗ
  ﺷﺠﻊ اﻟﻤﺒﺤﻮث ﻟﺬآﺮ أآﺜﺮ ﻣﻦ إﺟﺎﺑﺔ •
 
   اﻟﺘﻠﻔﺰﻳﻮن-2 اﻹذاﻋﺔ          -1
  اﻟﻜﻨﺎﺋﺲ/رﺟﺎل اﻟﺪﻳﻦ/واﻟﺨﻼوى/ اﻟﺠﻮاﻣﻊ-3
   اﻟﻨﺪوات اﻟﻌﺎﻣﺔ واﻟﻤﺤﺎﺿﺮات-4
   اﻟﺴﻴﻨﻤﺎ اﻟﻤﺘﺠﻮﻟﺔ-5
  اﻟﻤﻨﺎهﺞ اﻟﺘﻌﻠﻴﻤﻴﺔ/  اﻟﻤﺪارس -7
  اﻟﻘﺮﻧﺎء/  اﻷﺻﺪﻗﺎء -8
  اﻟﻨﺸﺮات/  اﻟﻜﺘﻴﺒﺎت -9
  اﻟﺪراﻣﺎ/  اﻟﻤﺴﺮح -01
  .............. ﻏﻴﺮ ذﻟﻚ ﺣﺪد -11
 ﺗﻌﺮف /  ﻻ ﻳﻌﺮف -88
  
  
- 12 - 
  ﺧﺎص ﺑﻤﺮض اﻟﺪرن : اﻟﻘﺴﻢ اﻟﺴﺎدس  
  
رﻗﻢ 
 اﻟﺴﺆال
اﻻﺟﺎﺑﺎت /رﻗﻢ اﻻﺟﺎﺑﺔ  اﻻﺟﺎﺑﺎت اﻟﻤﺤﺘﻤﻠﺔ و ارﻗﺎم ﺗﺮﻣﻴﺰهﺎ  ﻣﻀﻤﻮن اﻟﺴﺆال
  اﻟﻤﻨﺎﺳﺒﺔ
  اﻧﺘﻘﻞ اﻟﻲ
إن . ﻟﻤﻘﺎﺑﻞأآﺘﺐ ﻋﺪد اﻟﺴﻨﻮات ﻓﻰ اﻟﻌﻤﻮد ا  اﻟﻤﺮض اﻟﻌﻨﺪك دا ﺟﺎك ﻣﻦ ﻣﺘﻴﻦ؟  66
  (1)آﺎﻧﺖ اﻟﻤﺪة ﺳﻨﺔ أو أﻗﻞ ﻣﻦ ﺳﻨﺔ أآﺘﺐ 
  
     ﻻ-2 ﻧﻌﻢ                -1  ﺑﺘﺎﺧﺪي اي ﻋﻼﺟﺎت؟/هﺴﻊ ﺑﺘﺎﺧﺪ  76
     ﻻ-2 ﻧﻌﻢ                -1  اﺧﺪت اي ﻋﻼج ﻟﻠﺪرن ﻗﺒﻞ آﺪﻩ؟   86
   ﻣﺎ ﻓﻲ  ادوﻳﺔ ﺑﺎﻟﻮﺣﺪة اﻟﺼﺤﻴﺔ-1  اذا وﻗﻒ اﻟﻌﻼج، اﻟﺴﺒﺐ آﺎن ﺷﻨﻮ؟  96
  ش ﻣﺎ ﻋﻨﺪي ﻗﺮو-2
   ﻃﻮل ﻣﺪة اﻟﻌﻼج-3
اﻟﻤﺒﺤﻮث ﻟﻢ ﻳﺘﻠﻖ ﻋﻼج او ﻟﻢ )  ﻻﻳﻨﻄﺒﻖ -9
  (ﻳﺘﻮﻗﻒ ﻋﻦ اﻟﻌﻼج
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